abdullah's picture
Add files using upload-large-folder tool
8de7e09 verified
1
00:00:01,970 --> 00:00:06,570
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ูŠูˆู…
2
00:00:06,570 --> 00:00:10,790
ุฅู† ุดุงุก ุงู„ู„ู‡ ุงุญู†ุง ู†ุญูƒูŠ ููŠ ู…ุญุงุถุฑุฉ ุฌุฏูŠุฏุฉ ุจุนู†ูˆุงู†
3
00:00:10,790 --> 00:00:16,750
transplantation what's going on what are the
4
00:00:16,750 --> 00:00:26,250
mechanisms involved what are the new mechanisms
5
00:00:26,250 --> 00:00:31,590
involved in rejection ู‡ู†ุญูƒูŠ ุนู„ู‰ application of
6
00:00:31,590 --> 00:00:34,230
transplantation ู‡ู†ุญูƒูŠ ุนู„ู‰ hemopoietic stem cell
7
00:00:34,230 --> 00:00:39,050
transplantation ูˆู†ุดูˆู ุงู„ู…ุตุทู„ุญุงุช medical terms
8
00:00:39,050 --> 00:00:44,230
associated with transplantation ุจุดูƒู„ ุนุงู… ูƒู†ุง ุจู†ุนุฑู
9
00:00:44,230 --> 00:00:47,490
ุฃู†ู‡ ููŠ ุนู„ู‰ ุงู„ู€ tissue ูˆ ุงู„ู€ organs of the body
10
00:00:47,490 --> 00:00:52,950
ุฃู†ุชุฌูŠู† ุฃูŠุถุง ููŠ ุนู„ู‰ ุงู„ู€ white blood cell ุงู„ู€ MHC
11
00:00:52,950 --> 00:00:57,950
ุฃู†ุชุฌูŠู† these antigens are highly polymorphic among
12
00:00:57,950 --> 00:01:01,890
the population ูˆุจุงู„ุชุงู„ูŠุŒ ุงู„ุงุชุตุงู„ ุจูŠู† ู…ุณุชุฎุฏู… ูˆู…ุณุชุฎุฏู…
13
00:01:01,890 --> 00:01:02,830
ู…ุตุงู„ุญ ูˆู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
14
00:01:02,830 --> 00:01:03,150
ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
15
00:01:03,150 --> 00:01:07,650
ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
16
00:01:07,650 --> 00:01:09,770
ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
17
00:01:09,770 --> 00:01:10,530
ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
18
00:01:10,530 --> 00:01:14,110
ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
19
00:01:14,110 --> 00:01:17,870
ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู… ู…ุณุชุฎุฏู…
20
00:01:17,870 --> 00:01:22,750
ู…ุณุชุฎุฏู… ู…ุณุชุฎ
21
00:01:23,190 --> 00:01:28,590
ู‡ุฐู‡ ุงู„ุนู…ู„ูŠุฉ ู…ู† ุนู…ู„ูŠุฉ transplantation more common
22
00:01:28,590 --> 00:01:31,610
place ูŠุนู†ูŠ very common place ุจู…ุนู†ู‰ ุฃู† ุตุงุฑุช ููŠ
23
00:01:31,610 --> 00:01:38,330
ุนู…ู„ูŠุงุช ุงู„ู€ transplantation are common as possible
24
00:01:38,330 --> 00:01:43,010
ุงู„ููŠุฌูˆุฑ
25
00:01:43,010 --> 00:01:46,470
ู‡ุฐุง ุงู„ู„ูŠ ุจูŠุจูŠู† ุฃู† ุงู„ู€ relationship between donor
26
00:01:46,470 --> 00:01:47,190
and recipient
27
00:01:52,350 --> 00:01:56,990
ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† ุฃู†ูˆุงุน ุงู„ู€ graft ุงู„ุฃูˆู„ุงู†ูŠ ู‡ูˆ
28
00:01:56,990 --> 00:02:02,630
ุนุจุงุฑุฉ ุนู† autograft ุงู„ุฅู†ุณุงู† ู…ู…ูƒู† ูŠุงุฎุฏ ู…ู† ุฃูŠ ู…ูƒุงู† ููŠ
29
00:02:02,630 --> 00:02:08,790
ุฌุณู…ู‡ ู„ุฌุณู…ู‡ ููŠ ู…ูƒุงู† ุขุฎุฑ ุงุณุชุฎุฏุงู…ุงุชู‡ุง ูƒุซูŠุฑุฉ ููŠ ุงู„ุญุฑูˆู‚
30
00:02:08,790 --> 00:02:14,810
ูˆ ุจูŠุณู…ูˆู‡ ุงู„ู€ autograft ูˆ ููŠ ุงู„ู€ ู‡ุฐุง ุงู„ู†ูˆุน ู…ู† ุงู„ู€
31
00:02:14,810 --> 00:02:20,110
autograft ูŠุนู†ูŠ is not rejected it's taken ุงู„ู…ูˆุถูˆุน
32
00:02:20,110 --> 00:02:29,490
ุงู„ุซุงู†ูŠ ู…ู† ุงู„ู€ drafting ู‡ูˆ ุจูŠู† individual ุฃูˆ
33
00:02:29,490 --> 00:02:33,250
identical twins they have ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† the
34
00:02:33,250 --> 00:02:39,310
same MSC molecule ูˆุจุงู„ุชุงู„ูŠ ุฃูŠุถุง ุงู„ู€ graft is not
35
00:02:39,310 --> 00:02:43,880
rejected between these individual ู‡ูˆ ุงู„ุซุงู„ุซ ู…ู†
36
00:02:43,880 --> 00:02:48,700
ุงู„ู€Grafting ู‡ูˆ ุงู„ู€Grafting ุจูŠู† ู…ุฌู…ูˆุนุงุช ู…ุฎุชู„ูุฉ ู…ู†
37
00:02:48,700 --> 00:02:53,300
ู†ูุณ ุงู„ู…ุฌู…ูˆุนุงุช ูˆุจุงู„ุชุงู„ูŠ ู‡ู… ู„ุฏูŠู‡ู… ู…ูˆู„ูŠูƒูŠูˆู„ MSC
38
00:02:53,300 --> 00:02:57,140
ู…ุฎุชู„ูุฉ ู‡ุฐุง A ูˆู‡ุฐุง B ูˆุจุงู„ุชุงู„ูŠ ูŠุณู…ูˆู† ุงู„ู€Graft ููŠ ู‡ุฐู‡
39
00:02:57,140 --> 00:03:03,580
ุงู„ุญุงู„ุฉ Allograft ูˆุฃู†ุชู‡ู‰ ุงู„ู€Rejection ุฃูˆ ุจูŠู†
40
00:03:03,580 --> 00:03:09,710
ู…ุฌู…ูˆุนุงุช ู…ุฎุชู„ูุฉ ู…ู† ู…ุฌู…ูˆุนุงุช ู…ุฎุชู„ูุฉ ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู†
41
00:03:09,710 --> 00:03:14,830
ู‡ูŠ ุงู„ูุงุฑ ูˆุงู„ุฃุฌู†ุจ and this is called xenograft and
42
00:03:14,830 --> 00:03:19,870
it's also they have different antigenic molecule
43
00:03:19,870 --> 00:03:26,230
ู‡ูŠ MCX ูˆ MCA ูˆุจุงู„ุชุงู„ูŠ the graft is also it's
44
00:03:26,230 --> 00:03:30,590
called xenograft and rejected ู‡ุฐู‡ ู‡ูŠ ุฃู†ูˆุงุน ุงู„ู€
45
00:03:30,590 --> 00:03:36,090
grafting ู‡ุฐุง ู‡ูˆ autograft graft of transplant from
46
00:03:36,090 --> 00:03:39,450
one area to another of the same individual ุฒูŠ ู…ุง
47
00:03:39,450 --> 00:03:47,550
ู‚ู„ู†ุง ู„ูƒู… ู…ู…ูƒู† ููŠ ุญุงู„ุงุช ุงู„ุญุฑูˆู‚ ููŠ ุญุงู„ุงุช ุงู„ู€ on the
48
00:03:47,550 --> 00:03:52,330
same individual ู…ู…ูƒู† ุงู„ู€ graft ูŠุชุงุฎุฏ ูˆุฃู† ุงู„ู€ graft
49
00:03:52,330 --> 00:03:56,770
ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจูŠุนุชุจุฑ as autologous graft or self
50
00:03:56,770 --> 00:04:01,210
and the immune response will not induced against
51
00:04:01,210 --> 00:04:04,850
it ุงู„ู†ูˆุน ุงู„ุซุงู†ูŠ ุงู„ู„ูŠ ู‡ูˆ isograft ุฒูŠ ู…ุง ู‚ู„ู†ุง ุจูŠู†
52
00:04:04,850 --> 00:04:12,430
between isogenic or genetically identical twins
53
00:04:12,430 --> 00:04:20,130
or individual ูˆ it's also not rejected ุงุนุชุจุฑู‡ุง
54
00:04:20,130 --> 00:04:27,440
homozygotic or identical at once ูˆู‡ูŠ ุทุจุนุง ููŠ ู‡ุฐุง
55
00:04:27,440 --> 00:04:34,180
ุงู„ุญุงู„ุฉ the graft is described as histocompatible
56
00:04:34,180 --> 00:04:39,800
graft and individual ุงู„ู†ูˆุน ุงู„ุซุงู„ุซ ุงู„ู„ูŠ ู‡ูˆ allograft
57
00:04:39,800 --> 00:04:41,920
ุงู„ู„ูŠ ู‡ูˆ between different individual of the same
58
00:04:41,920 --> 00:04:46,100
species they have different MSC molecule because
59
00:04:46,100 --> 00:04:50,320
of the MSC is polymorphic among individual ุทุจุนุง ููŠ
60
00:04:50,320 --> 00:04:51,340
ู‡ุฐุง ุงู„ุญุงู„ุฉ ุจูŠูƒูˆู†
61
00:04:58,680 --> 00:05:14,740
ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช
62
00:05:14,740 --> 00:05:19,340
ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช
63
00:05:19,340 --> 00:05:20,060
ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช
64
00:05:20,060 --> 00:05:20,080
ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช
65
00:05:20,080 --> 00:05:20,100
ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†ุชุดุงุฑุงุช
66
00:05:20,100 --> 00:05:20,420
ุงู„ุงู†ุชุดุงุฑุงุช ุงู„ุงู†
67
00:05:24,520 --> 00:05:27,780
ุงู„ุฃู„ูˆุบุฑุงูุช ุนุงุฏุฉู‹ is rejected within the first two
68
00:05:27,780 --> 00:05:33,000
weeks ูˆ ุจูŠุณู…ูˆู‡ุง ุงู„ู€ first set rejection ููŠ ุญุงุฌุฉ
69
00:05:33,000 --> 00:05:38,400
ุงุณู…ู‡ุง second set rejection ุจุชุดูŠุฑ ุจุนุฏ ุณุชุฉ ุฅู„ู‰ ุซู…ุงู†
70
00:05:38,400 --> 00:05:43,620
ุฃูŠุงู… ูˆู‡ุฐุง ุจูŠูƒูˆู† due to specific immunological
71
00:05:43,620 --> 00:05:47,360
memory cell for the antigen expressed by the graft
72
00:05:47,360 --> 00:05:51,460
ูŠุนู†ูŠ ุดุงูุช ุงู„ู€ antigen ุฌุงู…ู„ ู‡ูŠูƒ ูˆ ุงุชู†ุดุทุช ุฃูˆ ุฑุณู„ุช
73
00:05:51,460 --> 00:05:54,910
ุนุงู…ู„ุฉ immune response ูˆุชูˆู„ุฏ ุนู† ุงู„ู€ immune response
74
00:05:54,910 --> 00:06:00,170
memory cell ู„ู…ุง ุนู…ู„ู†ุง drafting ุจูŠุตูŠุฑ ููŠู‡ ุฅูŠุด ุงู„ู€
75
00:06:00,170 --> 00:06:06,890
memory cell well rejected CD4 T cell play crucial
76
00:06:06,890 --> 00:06:10,770
role in rejection ููŠู‡ ู†ูุณ ุงู„ุญูƒุงูŠุฉ this can be
77
00:06:10,770 --> 00:06:15,030
proved by transferring these cells ูƒูŠ ุจู†ุฃูƒุฏ ุฃู† CD4
78
00:06:15,030 --> 00:06:19,100
T cell ู‡ูŠ ุงู„ุฃุณุงุณ ููŠ ุงู„ู…ูˆุถูˆุน ู‡ูŠ ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ู„ูˆ ุฌูŠู†ุง
79
00:06:19,100 --> 00:06:28,360
ูˆ ุญู‚ู†ู‡ุง ููŠ ุงูŠู‡ ุงูŠุดุŸ ุญู‚ู†ู‡ุง ููŠ identical twins or
80
00:06:28,360 --> 00:06:33,340
syngenic recipient ูˆุจุนุฏ ูุชุฑุฉ ุงุฌูŠู†ุง ุนู…ู„ู†ุง ู„ู‡
81
00:06:33,340 --> 00:06:39,260
grafting as the same graft ุงู„ู„ูŠ ูƒุงู† ู…ุนู…ูˆู„ ููŠ
82
00:06:39,260 --> 00:06:44,220
ุงู„ุงู†ุณุงู† ุงู„ู„ูŠ ุตุงุฑ ุนู†ุฏู‡ rejection ู‡ู„ุงุฌูŠ ุฃู† ุงู„ู€
83
00:06:44,220 --> 00:06:48,430
rejection second recipient also with the same ุชู‚ุงู„
84
00:06:48,430 --> 00:06:54,130
ู„ู‡ graft ู‡ูŠุนู…ู„ second rejection ุฃูˆ set rejection
85
00:06:54,130 --> 00:06:57,110
ุฅูŠุด ูŠุนู†ูŠ second set ูŠุนู†ูŠ ู‡ูŠุตูŠุฑ ููŠู‡ rejection
86
00:06:57,110 --> 00:07:02,910
earlier than the first rejection ุฃุนูŠุฏู‡ุง ุซุงู†ูŠ ู…ุฑุฉ
87
00:07:02,910 --> 00:07:08,370
ุซุงู†ูŠุฉ ูˆุงุญุฏ ุตุงุฑ ููŠ ุนู†ุฏู‡ ุงูŠุด rejection first set
88
00:07:08,370 --> 00:07:15,490
rejection ุจุนุฏ ุฃุณุจูˆุนูŠู† ุณุจุจ ููŠ ุฐู„ูƒ ู†ุดุงุท ู„ู„ู€ CD4 CD4 ู‡ูŠ
89
00:07:15,490 --> 00:07:20,490
ุงู„ุฃุณุงุณ ูƒูŠู ุฃุซุจุช ุฃู† CD4 ู‡ูŠ ุงู„ุฃุณุงุณ ู„ุฃู†ู‡ ู„ูˆ ุฃุฎุฏู†ุงู‡ุง
90
00:07:20,490 --> 00:07:26,670
ูˆ ุฃุญู‚ู†ู‡ุง ููŠ single individual ูŠุนู†ูŠ identical twins
91
00:07:26,670 --> 00:07:34,430
ูˆ ุฑูˆุญู†ุง ุจุนุฏ ู…ุง ู†ุญู‚ู†ู‡ุง ุฑูˆุญู†ุง ุฃุฏูŠู†ุง ุงู„ู€ twins ู‡ุฐุง
92
00:07:34,430 --> 00:07:38,730
ุฃุฏูŠู†ุงู‡ ู†ูุณ ุงู„ู€ CD4 ุนู…ู„ู†ุง ู„ู‡ drafting from the same
93
00:07:38,730 --> 00:07:42,850
draft ุงู„ู„ูŠ ูƒุงู† ููŠ ุงู„ุฃูˆู„ ู‡ุชู„ุงู‚ูŠ ุฃู† ุตุงุฑ ููŠ second
94
00:07:42,850 --> 00:07:48,990
seed rejection ุนู†ุฏ ุงู„ู€ individual ู„ูŠุดุŸ ุทุจุนุง ู„ุฃู† ุงู„ู€
95
00:07:48,990 --> 00:07:52,990
CD4 ู…ูˆุฌูˆุฏุฉ ุจุงู„ูุนู„ ูˆุจุงู„ุชุงู„ูŠ ูˆูƒุฃู†ู†ุง ุจู†ุนู…ู„ ุงูŠู‡ุŸ
96
00:07:52,990 --> 00:07:58,370
secondary immune response ู‡ูŠูƒูˆู† easier ูˆ faster
97
00:07:58,370 --> 00:08:04,350
ูˆู‡ูŠูƒูˆู† ููŠ rejection ุฃูƒุชุฑ ุฏู„ูˆู‚ุชูŠ ุฃู† ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง
98
00:08:04,350 --> 00:08:11,090
ุงุชู†ุดุทุช ูˆู‡ูŠ ุงู„ู„ูŠ ุนู…ู„ุช ุงู„ู€ rejection ุฃูŠ ุดุฎุต ูŠุณุชุทูŠุน
99
00:08:11,090 --> 00:08:15,270
ุฃูŠุถุง ุฃู† ูŠุดุชุบู„ ููŠ ุงู„ุงู†ุชุฌุงุฑุงุช ุงู„ุชุดูˆูŠุฉ ููŠ ุงู„ุงู†ุชุฌุงุฑุงุช
100
00:08:15,270 --> 00:08:19,890
ุงู„ุชุดูˆูŠุฉ ููŠ ุงู„ุงู†ุชุฌุงุฑุงุช ุงู„ุชุดูˆูŠุฉ ููŠ ุงู„ุงู†ุชุฌุงุฑุงุช
101
00:08:19,890 --> 00:08:32,890
ุงู„ุชุดูˆูŠุฉ ููŠ ุงู„ุงู†ุชุฌุงุฑุงุช ุงู„ุชุดูˆูŠุฉ ููŠ ุงู„ุงู†ุชุฌุงุฑุงุช
102
00:08:32,890 --> 00:08:36,490
ุงู„ุชุดูˆูŠุฉ ูˆุทุจุนุง ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ุฏู„ูŠู„ ุนู„ู‰ ุฃู† ููŠ ุฏูŠ
103
00:08:36,490 --> 00:08:42,130
ุฏู„ูˆู‚ุชูŠ hypersensitivity of CD4 ูˆ CD8 ุงุดุชุบู„ูˆุง ูˆ
104
00:08:42,130 --> 00:08:46,330
ู‡ู… ุงู„ู„ูŠ ุนู…ู„ูˆุง ุงู„ู€ rejection
105
00:08:50,240 --> 00:08:54,580
animal that lack T lymphocyte ู‡ุฐุง ุฏู„ูŠู„ ุขุฎุฑ ุนู„ู‰ ุฃู†
106
00:08:54,580 --> 00:08:58,540
T cell ู‡ูŠ ุงู„ุฃุณุงุณ ุงู„ู†ุงุณ ุงู„ู„ูŠ ู…ุง ุนู†ุฏู‡ุงุด T lymphocyte
107
00:08:58,540 --> 00:09:02,560
will not reject allograft or even xenograft
108
00:09:02,560 --> 00:09:08,000
process of rejection slow down ูˆู‚ุช ุงูŠุด ู‚ุงู„ูˆุง ุฅุฐุง
109
00:09:08,000 --> 00:09:10,880
ูƒุงู† ุงุณุชุฎุฏู…ู†ุง ู…ู†ู‡ suppressive drug
110
00:09:13,680 --> 00:09:16,620
Category of allograft rejection ู‚ุงู„ูˆุง ููŠ ุนู†ุฏู†ุง ุซู„ุงุซ
111
00:09:16,620 --> 00:09:19,860
ุฃู†ูˆุงุน ู…ู† ุงู„ู€ rejection hyper acute ูˆ acute ูˆ ู‚ุฑูŠุจุง
112
00:09:19,860 --> 00:09:23,820
ูˆ chronic ุทุจุนุง ุงู„ู€ hyper acute ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู†
113
00:09:23,820 --> 00:09:27,680
it occurs within few minutes to few hours of
114
00:09:27,680 --> 00:09:33,120
transplantation ูˆุงู„ุณุจุจ ููŠ ุฐู„ูƒ ุฃู† transplanted is
115
00:09:33,120 --> 00:09:37,420
destroyed by preformed antibody ู„ู…ูŠู†ุŸ to
116
00:09:37,420 --> 00:09:40,980
incompatible MSC antigen ููŠ already ู…ูˆุฌูˆุฏุฉ
117
00:09:40,980 --> 00:09:46,880
antibody ุฌุงู‡ุฒุฉ ู…ู† ุงูŠุด ุจุชุนู…ู„ุŸ ุจุชุนู…ู„ ุงูŠุดุŸ ุจุชุดุชุบู„ ุถุฏ
118
00:09:46,880 --> 00:09:50,960
ุงู„ุงูŠุดุŸ ู„ู…ูˆู„ูŠูƒูˆู„ ุงู„ู„ูŠ ุฏุฎู„ from the donor or
119
00:09:50,960 --> 00:09:53,560
even sometime to carbohydrate expressed on
120
00:09:53,560 --> 00:09:57,920
transplanted tissue ูˆุจุงู„ุชุงู„ูŠ ุนู„ู‰ ุทูˆู„ ุจูŠุตูŠุฑ ููŠู‡ ุงูŠุด
121
00:09:57,920 --> 00:10:02,500
rejection ุทุจุนุง ุฃู† ุงู„ู€ antibody ู‡ุฐูŠ ุฌุงูŠุฉ ูŠุงู„ูˆ it can
122
00:10:02,500 --> 00:10:06,400
be present from or results from previous
123
00:10:06,400 --> 00:10:11,350
transplantation ุฃูˆ blood transfusion ุฃูˆ Multiple
124
00:10:11,350 --> 00:10:16,190
Pregnancy ุชู„ุงู‚ูŠ ููŠู‡ ูƒู„ ู…ุฑุฉ ุจูŠุชูƒูˆู† Antibody For
125
00:10:16,190 --> 00:10:18,790
Foreign Antigen ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ Multiple
126
00:10:18,790 --> 00:10:26,130
Antibody ุนู†ุฏ ุงู„ุณุช ุงู„ุญุงู…ู„ ูˆู‡ุฐู‡ ู…ู…ูƒู† ู„ูˆ ุนู…ู„ู†ุง ู„ู‡ุง
127
00:10:26,130 --> 00:10:30,090
transplantation ุชุนู…ู„ rejection ุทุจ ุนู†ุฏ ู‡ุฐู‡
128
00:10:30,090 --> 00:10:33,170
ุงู„ุงู†ุชุจุงุฏูŠ antibody are called cytotoxic antibody
129
00:10:33,170 --> 00:10:37,050
and that can activate complement ุนู„ู‰ ุงู„ู…ุทุฑุญ ูˆู…ุด ุจุณ
130
00:10:37,050 --> 00:10:40,760
ุชุนู…ู„ platelet activation ูŠุนู†ูŠ ููŠู‡ ุฌู„ุทุฉ ูˆ
131
00:10:40,760 --> 00:10:44,320
Interstitial Hemorrhage in transplanted tissue
132
00:10:44,320 --> 00:10:49,520
which decreased blood flow in it ูŠุนู†ูŠ ุดูˆ ุงู„ู„ูŠ
133
00:10:49,520 --> 00:10:52,660
ุจูŠุตูŠุฑ ุจูŠุตูŠุฑ ุฌู„ุทุฉ ูˆุจุนุฏ ุงู„ุฌู„ุทุฉ ุจูŠุตูŠุฑ ุชูุญู‚ ูˆุจุชุตูŠุฑ
134
00:10:52,660 --> 00:10:58,420
ู†ุฒูŠุฑ ูˆุจุงู„ุฅุถุงูุฉ ู„ุฅู†ู‡ ููŠ distraction ู„ู„ุฅูŠุด ู„ู„
135
00:10:58,420 --> 00:11:04,640
transplanted tissue ุงู„ู…ุญุตู„ุฉ ุชุฏุฑ ูƒู„ุงู… infraction or
136
00:11:04,640 --> 00:11:07,720
tissue damage ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠ decrease in blood
137
00:11:07,720 --> 00:11:12,020
flow ููŠ ู‡ุฐู‡ ุงู„ู…ู†ุทู‚ุฉ ูˆ ูƒู…ุง ุชุดุงู‡ุฏูˆู†ุŒ ุงู„ู€ Cell
138
00:11:12,020 --> 00:11:14,320
-mediated immunity ู„ู‡ุง ู„ูŠุณ ู„ู‡ุง ุฃูŠ ุฏูˆุฑ ููŠ ุงู„ู€
139
00:11:14,320 --> 00:11:18,200
Hyperacute Rejection ูƒู„ู‡ุง ุงู„ู„ูŠ ุจูŠุญูƒูŠ ุนุจุงุฑุฉ ุนู†
140
00:11:18,200 --> 00:11:22,420
Antibody Sitotoxic Antibody Only Present to the
141
00:11:22,420 --> 00:11:28,340
transplanted tissue ุงู„ู€
142
00:11:28,340 --> 00:11:29,420
Acute Rejection
143
00:11:33,290 --> 00:11:37,410
ุชุญุฏุซ ููŠ ู…ุณุชุฎุฏู… ู„ู… ูŠูƒู† ู‚ุจู„ ุฐู„ูƒ ูŠูƒูˆู† ู…ุฑุชุจุท
144
00:11:37,410 --> 00:11:41,130
ุจุงู„ุชุฑุงู†ุณุจู„ุงู†ุช ู…ุง ุดุงูุด ุงู„ุชุฑุงู†ุณุจู„ุงู†ุช ู‚ุจู„ ู‡ูŠูƒ ูˆุจุชุงู„ูŠ
145
00:11:41,130 --> 00:11:44,950
ู‡ูˆ ู„ูŠุณ ู…ุฑุชุจุท ุจุฐู„ูƒ ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑุŸ ู‚ุงู„ูˆุง ุชูŠู„ูŠู†ููˆุณูŠูŠุช
146
00:11:44,950 --> 00:11:48,890
ุจุชุชู†ุดุท if the rejection is due to T cell
147
00:11:48,890 --> 00:11:53,210
activation ูˆ it can be activation either by direct
148
00:11:53,210 --> 00:11:57,230
recognition to the alloantigen or indirectly ู†ุญู†
149
00:11:57,230 --> 00:12:02,100
ุดูˆููˆุง transplant tissue is mismatch ูˆุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ
150
00:12:02,100 --> 00:12:03,120
ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ
151
00:12:03,120 --> 00:12:08,440
ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ
152
00:12:08,440 --> 00:12:11,160
ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ
153
00:12:11,160 --> 00:12:12,000
ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ
154
00:12:12,000 --> 00:12:12,280
ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ
155
00:12:12,280 --> 00:12:14,540
ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ ุงู†ุชู‚ุฑ Cell-mediated
156
00:12:14,540 --> 00:12:17,900
immunities manifested by intense infiltration of
157
00:12:17,900 --> 00:12:21,600
lymphocyte and macrophage ุทุจุนุง ู‡ู†ุญูƒูŠ ุนู„ู‰ cell
158
00:12:21,600 --> 00:12:24,580
-mediated immunity ุทุจุนุง ูู‡ู†ุง ู†ุดุท ููŠู‡ุง ุงู„
159
00:12:24,580 --> 00:12:28,800
macrophage ู…ูŠู† ู†ุดุทู‡ุง ุงู„ T-lymphocytes ุจุนุฏ ู…ุง ุชู‚ุฏู…
160
00:12:28,800 --> 00:12:34,320
ุฅู„ูŠู‡ุง ุงู„ antigen and it can be recognized by T
161
00:12:34,320 --> 00:12:37,560
-lymphocytes easily ูŠูˆู… ูŠุชู‚ุฏู… by antigen
162
00:12:37,560 --> 00:12:44,610
presenting cell ูุจุชู†ุดุท ุงู„ macrophage ูˆุจุงู„ุชุงู„ูŠ ุชุตุจุญ
163
00:12:44,610 --> 00:12:52,310
ู‡ู†ุงูƒ destruction ู„ุง ุชุดู‡ุฑ ูƒู…ุง ุชุดุงู‡ุฏูˆู† ููŠ ุงู„ุงุฎูŠุฑุฉ
164
00:12:52,310 --> 00:12:57,650
ุงู„ุงู†ุชุฌุงุฑ ุงู„ู…ูŠู†ูˆ ุณุงุจุฑุณุงู†ุชุฑุงุจูŠ ุฃูˆ ู…ูŠู†ูˆ ุณุงุจุฑุณุงู†ุชุฑุงุจูŠ
165
00:12:57,650 --> 00:13:06,710
ูŠู…ูƒู† ุฃู† ูŠุชุฃุฎุฐ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ
166
00:13:06,710 --> 00:13:09,790
ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ
167
00:13:09,790 --> 00:13:11,090
ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ
168
00:13:11,090 --> 00:13:15,600
ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุงู„ุงุชุฌุงุฑ ุจุนุฏ ุฃุดู‡ุฑ
169
00:13:15,600 --> 00:13:23,200
ุทูˆูŠู„ุฉ ูˆ ู…ุฑุงุช ุณู†ูˆุงุช ุทูˆูŠู„ุฉ ู„ุฅู†ุดุงุก
170
00:13:23,200 --> 00:13:25,520
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
171
00:13:25,520 --> 00:13:26,020
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
172
00:13:26,020 --> 00:13:29,640
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
173
00:13:29,640 --> 00:13:32,380
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
174
00:13:32,380 --> 00:13:42,120
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„
175
00:13:42,270 --> 00:13:45,750
is characterized by slow progressive loss of
176
00:13:45,750 --> 00:13:49,070
function ูŠุนู†ูŠ ููŠ ุงู„ุขุฎุฑ ุจูŠุตูŠุฑ ููŠู‡ infarct in the
177
00:13:49,070 --> 00:13:54,630
organ role
178
00:13:54,630 --> 00:13:57,750
of MRC molecule ุงู†ู‚ู„ ู„ู‡ graft reduction ุฎู„ูŠู†ุง
179
00:13:57,750 --> 00:14:06,570
ู†ุชุนุฑู ุดูˆูŠุฉ ุนู„ู‰ ุงู„ู…ูŠูƒุงู†ูŠุฒู…ุงุช ู‚ุงู„ูˆุง ุดูˆ
180
00:14:06,570 --> 00:14:09,070
ุจูŠุจุตูŠุฑุŸ ู‚ุงู„ูˆุง transplantation
181
00:14:10,990 --> 00:14:16,150
ุงู†ุชุฌู† ุฃูˆ MHC antigen ุจูŠุตูŠุฑ ู„ู‡ุง rejection ู„ุฃู† ุงู„ุฌู‡ุงุฒ
182
00:14:16,150 --> 00:14:21,090
ุงู„ู„ูŠ ู…ู†ู‡ุง ุงุชู†ุดุท ูˆ ุงู„ู€ MHC molecule has been
183
00:14:21,090 --> 00:14:27,910
recognized and these are cell surface proteins ูˆ
184
00:14:27,910 --> 00:14:31,570
ูƒู†ุง ุจู†ุนุฑู ุงู† ูƒู„ ุฎู„ุงูŠุง ุฌุณู… ุงู„ุฅู†ุณุงู† ุนู„ู‰ ุณุทุญู‡ุง MHC
185
00:14:31,570 --> 00:14:35,710
class 1 molecule ุจูŠู†ู…ุง MHC class 2 ู…ูˆุฌูˆุฏุฉ ุนู„ู‰
186
00:14:35,710 --> 00:14:39,140
ุงู„ู€ professional antigen presenting cell ูˆุจุงู„ุชุงู„ูŠ
187
00:14:39,140 --> 00:14:43,260
ุงู„ู€ immune response is directed will be directed
188
00:14:43,260 --> 00:14:49,240
predominantly ู„ู…ูŠู†ุŸ ู„ู„ู€ MSG class 1 molecule ูˆุงู„ู„ูŠ
189
00:14:49,240 --> 00:14:52,220
ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ูƒู„ ุฎู„ุงูŠุง ุฌุณู… ุงู„ุฅู†ุณุงู† ุจู…ุง ููŠู‡ุง ุงู„
190
00:14:52,220 --> 00:15:01,230
grafted tissue ุงู„ูุฑู† MSG molecule activate ุนุฏุฏ ู‡ุงุฆู„
191
00:15:01,230 --> 00:15:05,470
ู…ู† ุงู„ู€ T lymphocyte clone ููŠ ุงู„ู€ Recipient ูˆูŠู‚ุฏุฑูˆุง
192
00:15:05,470 --> 00:15:10,190
ุนุฏุฏู‡ุง ู„ู€ 5% ู…ู† ูƒู„ ุงู„ู€ T lymphocyte clone ุงู„ู…ูˆุฌูˆุฏุฉ
193
00:15:10,190 --> 00:15:15,550
ููŠ ุฌุณู… ุงู„ู€ Recipient ูˆ .. ุงู„ .. ุทุจุนุง ุงู„
194
00:15:15,550 --> 00:15:24,050
combination of non-self MSC molecule ู…ุน ุงู„ ..
195
00:15:24,050 --> 00:15:29,500
ุจูŠุจุชุงูŠุฏ ุงู„ู„ูŠ ู‡ูˆ Antigenic peptide ู‡ูŠุชูุงุนู„ูˆุง ู…ุน ุงู„ู€
196
00:15:29,500 --> 00:15:33,580
TCR expressed on many different T-cell clone
197
00:15:33,580 --> 00:15:39,460
ุจุชุชู†ุดุท ุงู„ู€ T-lymphocyte ูˆ ู‡ุชูุฑุฒู„ู†ุง ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€
198
00:15:39,460 --> 00:15:44,800
cytotoxic ุฃูˆ ุงู„ู€ certain cytokine can be secreted
199
00:15:44,800 --> 00:15:50,380
ู…ู† ุงู„ู„ูŠ ู‡ูˆ CD4 T-cell ูˆู‡ุฐู‡ ุจุชู†ุดุทู†ุง ุงู„ู€ cytotoxic T
200
00:15:50,380 --> 00:15:56,220
-cell ุงู„ู„ูŠ ู‡ุชุจุฏุฃ ุชู‡ุงุฌู… ุงู„ู€ foreign tissue mechanism
201
00:15:58,600 --> 00:16:01,880
of recognition ุฌุงู„ู‡ ููŠู‡ุง two mechanism of
202
00:16:01,880 --> 00:16:06,000
recognition either direct or indirect ุงู„ู„ูŠ ู‡ูˆ
203
00:16:06,000 --> 00:16:09,480
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
204
00:16:09,480 --> 00:16:10,660
recognition ุงู„ู„ูŠ ู‡ูˆ recognition ุงู„ู„ูŠ ู‡ูˆ
205
00:16:10,660 --> 00:16:11,240
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
206
00:16:11,240 --> 00:16:12,280
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
207
00:16:12,280 --> 00:16:12,780
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
208
00:16:12,780 --> 00:16:12,980
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
209
00:16:12,980 --> 00:16:13,340
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
210
00:16:13,340 --> 00:16:17,100
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
211
00:16:17,100 --> 00:16:18,200
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
212
00:16:18,200 --> 00:16:18,360
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
213
00:16:18,360 --> 00:16:19,420
recognition ุงู„ู€ direct recognition ุงู„ู„ูŠ ู‡ูˆ
214
00:16:19,420 --> 00:16:19,660
recognition ุงู„ู„ูŠ ู‡ูˆ recognition ุงู„ู„ูŠ ู‡ูˆ
215
00:16:19,660 --> 00:16:24,540
recognition ุงู„ู„ูŠ
216
00:16:25,460 --> 00:16:28,960
ูˆ ุงู„ู€ donor cell ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจุชู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ูƒ
217
00:16:28,960 --> 00:16:33,760
antigen presenting cell ูŠุนู†ูŠ ุฏุฎู„ุช ุฎู„ุงูŠุง ุบุฑูŠุจุฉ ุนู„ู‰
218
00:16:33,760 --> 00:16:40,340
ุณุทุญู‡ุง ุฃู…ุดูŠ ุบุฑูŠุจ ู‡ูŠ ู†ูุณู‡ุง ุงุชุนุฑูุช ุนู„ูŠู‡ุง telephosite
219
00:16:40,340 --> 00:16:44,990
of the host ูˆ ุงุนุชุจุฑุชู‡ุง antigen presenting cell
220
00:16:44,990 --> 00:16:55,650
ูˆุชุนุฑูุช ุนู„ู‰ ุงู„ู€ foreign antigen ุงู„ู€ indirect ุจุทุฑูŠู‚ุฉ
221
00:16:55,650 --> 00:17:02,270
ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ
222
00:17:02,270 --> 00:17:05,270
ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ
223
00:17:05,270 --> 00:17:06,030
ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ
224
00:17:06,030 --> 00:17:06,050
ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ
225
00:17:06,050 --> 00:17:09,150
ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†ุฏุฑุชู‡ุง ุจุทุฑูŠู‚ุฉ ุงู†
226
00:17:09,420 --> 00:17:16,040
ุจุชุนู…ู„ ุจุชุงุน ุงู„ู€ host cell ูŠุนู†ูŠ host cell ุจุชุงุน ุงู„
227
00:17:16,040 --> 00:17:23,760
host ุจุชุชุนุฑู ุนู„ู‰ ุงู„ู€ donor antigen ูˆุจุชุงุฎุฏู‡ ูˆุจุชุนู…ู„ู‡
228
00:17:23,760 --> 00:17:28,780
processing ูˆุจุชู‚ุฏู… ู„ู‡ุง ุงู„ู€ host cell ูŠุจู‚ู‰ ุญุงู„ุชูŠู†
229
00:17:28,780 --> 00:17:33,680
direct ูˆ indirect ุงู„ู€ direct donor cell ู‡ูŠ ู†ูุณู‡ุง
230
00:17:33,680 --> 00:17:37,400
ุจุชุนุชุจุฑ ูƒู€ antigen presenting cell ุจุชู‚ุฏู… ุงู„ู€ antigen
231
00:17:37,400 --> 00:17:41,710
ู„ู‡ุง ุงู„ู€ host ุงู„ู„ูŠ ู‡ูˆ Recipient T-Lymphocytes
232
00:17:41,710 --> 00:17:44,110
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ Recognition Direct
233
00:17:44,110 --> 00:17:49,730
Recognition ูˆ Indirect ุงู†ู‡ ุงู„ู„ู‡ ุงู„ู€ tissue The
234
00:17:49,730 --> 00:17:55,010
grafted tissue or donor derived cellular peptide
235
00:17:55,010 --> 00:17:59,910
ุงู„ู„ูŠ ุทุงู„ุน ู…ู† ุงู„ู€ peptide ู‡ูŠ ู†ูุณู‡ุง ุจุชุชุนุฑู ุนู„ูŠู‡ุง ุงู„ู„ูŠ
236
00:17:59,910 --> 00:18:02,290
ู‡ูˆ host antigen presenting cell ุฃูˆ ุงู„ู€ recipient
237
00:18:02,290 --> 00:18:08,190
ูˆุจุชู‚ุฏู…ู‡ุง ู„ู„ู€ T-Lymphocyte ุชุญุช ุงู„ู€ recipient ุงูƒุชุฑูˆู‡ุฐู‡
238
00:18:08,190 --> 00:18:14,770
ู‡ู…ุง ุงู„ุทุฑูŠู‚ุชูŠู† ุงูŠู‡ ููŠ ุงู„ู€ direct ู†ูุณ ุงู„ุฎู„ูŠุฉ ู‡ุฐุง ู‡ูŠ
239
00:18:14,770 --> 00:18:17,530
donor antigen presenting cell ู‚ุฏู…ุช ุงู„ู€ antigen
240
00:18:17,530 --> 00:18:22,770
ู…ุจุงุดุฑุฉ ู„ู…ู†ุŸ ู„ู€ T lymphocyte ูˆููŠ ุงู„ู€ indirect ู„ุฃ
241
00:18:22,770 --> 00:18:26,090
ูˆุงู„ู„ู‡ ู‡ู†ุง ุงู„ู€ recipient antigen presenting cell
242
00:18:26,090 --> 00:18:29,410
ุชุนุฑูุช ุนู„ู‰ ุงู„ู€ antigen ุฃุฎุฏุชู‡ ูˆุนู…ู„ุช ู„ู‡ processing
243
00:18:29,410 --> 00:18:32,590
ูˆู‚ุฏู…ุชู‡ ู„ู…ู†ุŸ ู„ู„ู€ host cell
244
00:18:38,100 --> 00:18:44,600
ู…ุงุฐุง ุญุตู„ ุจุนุฏ ุงูƒุชูุงุด ุชูŠู„ูŠู†ููˆุณูŠุช ู„ูŠู†ุฌ ูˆุงู„ุณุงูŠุชูˆูƒูŠู†
245
00:18:44,600 --> 00:18:49,000
ุจุชุทู„ุน ู…ู†ู‡ุง ููŠ ุงู„ุงู„ูˆ ุฌุฑุงูุช ุฑูŠุฌูŠูƒุดู† ู‚ุงู„ูˆุง ุงูƒุชูุงุด
246
00:18:49,000 --> 00:18:57,840
ุชุณูŠู„ ุจู†ุดุชู„ุงู„ู„ูŠ ู‡ูˆ Allo-specific CD4 ูˆ CD8-cell
247
00:18:57,840 --> 00:19:04,920
ุงู„ุฌู…ูŠุฉ ุงู„ู†ุดุท ู‡ูˆ CD4 ูˆ CD8 ุชูŠู„ูŠู†ููˆุณุงูŠุช ุงูˆู ุงู„ู„ูŠ
248
00:19:04,920 --> 00:19:08,420
ู‡ูˆ Allo
249
00:19:15,430 --> 00:19:19,870
ุฃุดู‡ุฑ ุงู„ู€ cytokine ุจุชุทู„ุน ุนูŠู„ุฉ ูˆ interferon alpha ูˆ
250
00:19:19,870 --> 00:19:24,690
beta ูˆ gamma ูˆ human necrosis factor alpha ูˆ beta
251
00:19:24,690 --> 00:19:31,200
ูˆุดูˆููˆุง ุฏูˆุฑ ูƒู„ ูˆุงุญุฏ ู…ู†ู‡ู…ุŒ ุงู„ู€ IL-2 ู‡ูˆ ุนุจุงุฑุฉ ุนู†
252
00:19:31,200 --> 00:19:34,620
ุณุงูŠุชูˆ ูƒุงุฆู† ู…ู‡ู… in the T-cell proliferation and
253
00:19:34,620 --> 00:19:38,180
differentiationุŒ ู„ู…ูŠู† ุจูŠุนู…ู„ differentiation ูˆ
254
00:19:38,180 --> 00:19:41,920
proliferationุŸ ู„ู€ cytotoxic ูˆ ู„ู€ T-Helper cellุŒ ูŠุนู†ูŠ
255
00:19:41,920 --> 00:19:45,400
ุจุชุชู†ุดุท T-Helper cell ุงู„ู„ูŠ ุจุชู†ุดุท ุงู„ู€ cytotoxic T
256
00:19:45,400 --> 00:19:50,620
-lymphocytes ูˆุจุงู„ุชุงู„ูŠ ูƒู…ุงู† delayed type
257
00:19:50,620 --> 00:19:53,580
hypersensitivity reaction is associated with
258
00:19:53,580 --> 00:19:54,440
allergic reaction.
259
00:19:56,980 --> 00:20:01,480
ู…ูŠุฉ ุงู„ู…ูŠุฉ ุชู‡ูŠ ุงู„ู€ T-cell ุจุชุชู†ุดุท ู„ุฃู†ู‡ ุงุชู‚ุฏู… ุงุชุนุฑูุช ุนู„ู‰
260
00:20:01,480 --> 00:20:05,120
ุฃู†ุชุฌูŠู† ุบุฑูŠุจ ูˆุจุงู„ุชุงู„ูŠ ู†ุดุทุงุช ุงู„ู€ T-cell cytotoxic ุชู‡ูŠ
261
00:20:05,120 --> 00:20:08,840
ุงู„ู€ Lymphocytes ูˆุนู…ู„ุช delay type of sensitivity reaction
262
00:20:08,840 --> 00:20:14,680
ุงู„ู„ูŠ ุฃุฏุช ุฅู„ู‰ the graft rejectionุŒ ุทูŠุจ ู‡ุฐุง ุจุงู„ู†ุณุจุฉ
263
00:20:14,680 --> 00:20:18,480
ู„ู€ Gamma InterferonุŒ ุดูˆ ุจูŠุนู…ู„ุŸ ุจูŠู‚ูˆู„ูˆุง ู…ู‡ู… ุฌุฏุง
264
00:20:18,480 --> 00:20:22,870
in the activation of macrophageุŒ ูˆุจุงู„ุชุงู„ูŠ ุดูˆ ุจุชุนู…ู„ุŸ ุฌุงุฑูŠ
265
00:20:22,870 --> 00:20:26,070
ุงู„ู…ูƒุฑูˆููŠุฌ ุจุชู‡ุงุฌุฑุŒ it's recruitedุŒ it's migrated
266
00:20:26,070 --> 00:20:30,070
ู„ู…ูŠู†ุŸ to the grafted areaุŒ ูˆู‡ู†ุงูƒ ุจุชุนู…ู„ tissue
267
00:20:30,070 --> 00:20:35,750
damageุŒ ุงู„ู€ Tumor Necrosis Factor BetaุŒ ู‡ุฐุง ุนุจุงุฑุฉ ุนู†
268
00:20:35,750 --> 00:20:41,450
cytotoxic to the cellsุŒ ุฃูŠ cells ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ู€
269
00:20:41,450 --> 00:20:48,120
graftุŒ ุงู„ุขู† ุงู„ู€ Interferon Alpha ูˆBeta ูˆTumor Necrosis
270
00:20:48,120 --> 00:20:52,340
Factor Beta ูˆTumor Necrosis Factor AlphaุŒ ู‡ุฏูˆู„ ู…ุด
271
00:20:52,340 --> 00:20:54,760
ุจูŠุนู…ู„ูˆุง ุจูŠุฒูˆุฏูˆุง ุงู„ู€ expression of MHC Class I
272
00:20:54,760 --> 00:20:58,860
ู…ู„ูŠูƒูŠูˆู„ุŒ ุจูŠู†ู…ุง ุงู„ู€ Gamma Interferon ุจุชุฒูˆุฏ ุงู„ู€
273
00:20:58,860 --> 00:21:04,840
expression of Class II ู…ู„ูŠูƒูŠูˆู„ุŒ ูˆูŠู†ุŸ ุนู„ู‰ ุณุทุญ ุงู„ู€ Host
274
00:21:04,840 --> 00:21:09,690
ูˆุนู„ู‰ ุณุทุญ ุงู„ู€ AllograftุŒ ุดูˆ ุจุชุนู…ู„ ุจุฐุงู„ ุงู„ู€ expression
275
00:21:09,690 --> 00:21:14,090
of MHC moleculeุŸ ุฒุงุฏ ู…ุนู†ุงุชู‡ ุงู„ู€ effectiveness of
276
00:21:14,090 --> 00:21:18,050
antigen recognition ูˆ ุงู„ู€ enhancement of the graft
277
00:21:18,050 --> 00:21:22,370
rejection will be increasedุŒ ุทุจุนุง ุชุนุชู…ุฏ ุนู„ู‰ ุงู„ู€
278
00:21:22,370 --> 00:21:25,150
micro environment ููŠ ุงู„ู€ peripheral lymphoid organsุŒ
279
00:21:25,150 --> 00:21:31,170
ูŠุนู†ูŠ ุงู„ู€ CD4 helperุŒ CD4 T cell can differentiate
280
00:21:31,170 --> 00:21:36,350
into different types of effector cellุŒ ูˆุทุจุนุง ุชุฏูŠู†ุง
281
00:21:36,350 --> 00:21:41,710
different types of immune responsesุŒ ูุชุดูˆููˆุง ุฅูŠุด
282
00:21:41,710 --> 00:21:47,110
ุจูŠุตูŠุฑ ูƒุงู†ูˆุง ููŠ ูˆุฌูˆุฏ ุงู„ู€ IL-12 ุงู„ู„ูŠ ุจุชุชู†ุดุท ุฏูŠ ุงู„ู€ T-cell
283
00:21:47,110 --> 00:21:52,970
ูˆู‡ุฐู‡ ุญุตู„ุชู‡ุง ุฅูุฑุงุฒ Gamma Interferon ุงู„ู„ูŠ ุจุชู†ุดุท ุงู†ู‡ุง
284
00:21:52,970 --> 00:21:57,790
Macrophage ูˆุจุชูƒูˆู† ุงู„ู€ delayed type hypersensitivity
285
00:21:57,790 --> 00:22:04,940
ูˆููŠ ูˆุฌูˆุฏ ุงู„ู€ IL-4 ุฏูŠ ุงู„ู€ T-cell ุงู„ู„ูŠ ุจุชุชู†ุดุท ูˆุจุชุทู„ุน ุงู„ู€ IL
286
00:22:04,940 --> 00:22:11,060
-5 ุงู„ู„ูŠ ุจู†ุดุท ุงู„ู€ Eosinophilic ูŠุนู†ูŠ population ูˆุจูŠุนู…ู„
287
00:22:11,060 --> 00:22:15,560
rejectionุŒ ูˆููŠ ูˆุฌูˆุฏ ุงู„ู€ Transforming Growth Factor
288
00:22:15,560 --> 00:22:24,240
BetaุŒ IL-6 ูˆ IL-23 ู‡ู… ุงู„ู„ูŠ ุจูŠุทู„ุนูˆุง ู‚ุงู„ูˆุง ุงู„ู€ T-Helper 17
289
00:22:24,240 --> 00:22:29,400
ู‡ูŠ ุงู„ู„ูŠ ุจุชุชู†ุดุท ูˆ can activate neutrophilic
290
00:22:29,400 --> 00:22:32,900
rejectionุŒ ุฃู…ุง ููŠ ูˆุฌูˆุฏ ุงู„ู€ Transforming Growth
291
00:22:32,900 --> 00:22:40,620
Factor Beta ู„ุญุงู„ู‡ุŒ T-reg ู‡ูŠ ุงู„ู„ูŠ ุจุชุชู†ุดุท ูˆุจุชุนู…ู„
292
00:22:40,620 --> 00:22:43,600
ุงู†ู‡ูŠุจุดู† ู„ูƒู„ ุงู„ู€ immune response activityุŒ ูˆุจุงู„ุชุงู„ูŠ
293
00:22:43,600 --> 00:22:49,320
ุจูŠุตูŠุฑ ููŠู‡ promotion ู„ู„ู€ Allograft acceptance by
294
00:22:49,320 --> 00:22:52,600
multiple mechanismุŒ ู…ุด rejectionุŒ ุจุชุนู…ู„ Inhibition
295
00:22:52,600 --> 00:22:56,420
acceptanceุŒ ูŠุจู‚ู‰ ููŠู‡ different InhibitionุŒ different
296
00:22:56,420 --> 00:23:00,420
immune response ุจุชุตูŠุฑ according to the different
297
00:23:00,420 --> 00:23:07,150
environmentุŒ Presence ููŠ ู…ู†ุทู‚ุฉ ุงู„ู€ Host ุงู„ู€ rejection ูˆ
298
00:23:07,150 --> 00:23:14,150
ูƒู…ุง ุชุดุงู‡ุฏูˆู† ู†ูุณ ุงู„ู€ Figure ุงู„ุชูŠ ุชูˆุงุญู‚ู†ุงู‡ุงุŒ IL 12
299
00:23:14,150 --> 00:23:21,090
ู†ุดุทุช ู„ู†ุงุŒ IL 12 ู†ุดุทุช ู„ู†ุง ุงู„ู€ T-cell ุงู„ู„ูŠ ุทู„ุนุช Gamma
300
00:23:21,090 --> 00:23:26,270
InterferonุŒ ู†ุดุทุช ุงู„ู€ MacrophageุŒ IL 4 ููŠ ูˆุฌูˆุฏ IL 4 ุงู„ู€ T-cell
301
00:23:26,270 --> 00:23:27,970
ู†ุดุทุช ูˆุทู„ุนุช IL 5
302
00:23:36,530 --> 00:23:40,830
ุจุชู†ุดุท T-Helper 17 ุจุชุทู„ุน IL 17 ูˆุจูŠุนู…ู„
303
00:23:40,830 --> 00:23:47,270
Neutrophilic RejectionุŒ ูˆุชู†ุดุท
304
00:23:47,270 --> 00:23:48,570
T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท
305
00:23:48,570 --> 00:23:50,250
T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท
306
00:23:50,250 --> 00:23:52,210
T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท
307
00:23:52,210 --> 00:23:52,670
T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท
308
00:23:52,670 --> 00:23:57,570
T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท T-Helper 13ุŒ ุชู†ุดุท
309
00:24:01,280 --> 00:24:09,100
ู…ุง ู‡ูŠ ุงู„ูุญูˆุตุงุช ุงู„ุชูŠ ุชุฌุฑู‰ ู„ู€ Tissue TypingุŸ ูŠุชุนุฑู
310
00:24:09,100 --> 00:24:13,180
ุนู„ู‰ ุงู„ู€ MHC molecule ุนู„ู‰ ุณุทุญ ุงู„ู€ Donor ู…ุฌู…ูˆุนุฉ ู…ู‚ุงูˆู…ุฉ
311
00:24:13,180 --> 00:24:17,760
ุฃูˆ ู…ุง ูŠุณู…ู‰ ุจุงู„ู€ Cross-matchingุŒ ู‡ูŠ ุชูุนู„ู‡ุง ู„ุชุฎู„ุต ู…ู†
312
00:24:17,760 --> 00:24:20,620
ูุฑุตุฉ ุงู„ู€ Graft rejectionุŒ ูŠุณู…ูˆู† ู‡ุฐู‡ ุงู„ุญูƒุงูŠุฉ
313
00:24:20,620 --> 00:24:27,700
Lymphocyte Phenotyping ุฃูˆ PhenotypingุŒ Tissue TypingุŒ ุชุชุฌุฑู‰
314
00:24:27,700 --> 00:24:35,570
ู„ุชุญุฏูŠุฏ ุงู„ู€ุŒ ู‡ุฐู‡ ุงู„ุชุญุฏูŠุฏุงุช ุจุชุญุฏูŠุฏ ุฏุฑุฌุฉ ุงู„ูุฑู‚ ุจูŠู†
315
00:24:35,570 --> 00:24:39,050
ุงู„ุงุซู†ูŠู†ุŒ ุงู„ุงุซู†ูŠู†ุŒ ุงู„ุงุซู†ูŠู†ุŒ ุงู„ุงุซู†ูŠู†ุŒ ุงู„ุงุซู†ูŠู†ุŒ ุงู„ุงุซู†ูŠู†ุŒ ุงู„ุงุซู†ูŠู†
316
00:24:39,050 --> 00:24:40,590
ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†
317
00:24:40,590 --> 00:24:41,510
ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†
318
00:24:41,510 --> 00:24:41,770
ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†
319
00:24:41,770 --> 00:24:48,650
ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†
320
00:24:48,650 --> 00:24:56,550
ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†ูŠู†ุŒ ุงุซู†
321
00:24:56,900 --> 00:25:01,580
ูˆุชุจุฏุฃ ุจุชุญุฏูŠุฏ
322
00:25:01,580 --> 00:25:06,800
ุงู„ู€ Antigen ุงู„ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ุฎู„ุงูŠุงุŒ ุงู„ู€ Positive reaction
323
00:25:06,800 --> 00:25:10,880
ุญูŠูƒูˆู† ููŠู‡ ู…ูˆุฌูˆุฏ ุงู„ู€ HLA-A ูˆุงู„ู„ูŠ ู…ุงุตุงุฑุด ููŠู‡ุง reaction
324
00:25:10,880 --> 00:25:15,580
ุญูŠูƒูˆู† ููŠู‡ Negative ู„ู„ู€ HLA-AุŒ ุทุจุนุง ุงู„ู€ Antisera ู…ู…ูƒู†
325
00:25:15,580 --> 00:25:21,250
ุชุฌูŠุจู‡ุง ู…ู† ุฃูƒุซุฑ ู…ู† ู…ูƒุงู†ุŒ ู…ู† ุถู…ู†ู‡ุง ุงู„ุงุดุฎุงุต ุงู„ู„ูŠ ูƒุงู†
326
00:25:21,250 --> 00:25:27,190
ู„ุฏูŠู‡ ู…ุฑุชุจุทุงุชุŒ ู…ุฑุชุจุทุงุช ูƒุซูŠุฑุฉุŒ
327
00:25:27,190 --> 00:25:30,870
ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ
328
00:25:30,870 --> 00:25:30,930
ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ
329
00:25:30,930 --> 00:25:32,110
ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ
330
00:25:32,110 --> 00:25:34,910
ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ
331
00:25:34,910 --> 00:25:38,350
ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ
332
00:25:38,350 --> 00:25:39,950
ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ ุฃูˆ ู…ุฑุชุจุทุงุชุŒ
333
00:25:47,330 --> 00:25:51,970
can be used for this purposeุŒ ุฅุฐุง ุจุฏูƒ ุฅูŠุงู‡
334
00:25:51,970 --> 00:25:56,610
automated ูŠุนู†ูŠุŒ ุฃูˆ ุจุฏูƒ ุฅูŠุงู‡ quantitative
335
00:25:56,610 --> 00:26:01,870
Lymphocyte cytotoxicity ู‡ูˆ ุนุจุงุฑุฉ ุนู† ูุญุต ุซุงู†ูŠ ุฃูŠุถุง
336
00:26:01,870 --> 00:26:05,830
ู…ุณุชุฎุฏู… ููŠู‡ antibody specific to MHC molecule antibody
337
00:26:05,830 --> 00:26:12,210
ููŠ ูˆุฌูˆุฏ ุงู„ู€ complementุŒ ุทุจุนุง complement ู…ุน antibody
338
00:26:12,210 --> 00:26:18,760
ุงู„ู€ antibody will fix the complementุŒ ูˆุจุงู„ุชุงู„ูŠ ู‡ูŠุนู…ู„
339
00:26:18,760 --> 00:26:22,580
damage ู„ู„ู€ target cell which are ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„ู€
340
00:26:22,580 --> 00:26:28,360
lymphocytesุŒ ูุฅุฐุง ุญุตู„ ููŠู‡ damage ุจุฏูˆ ูŠูƒูˆู† ููŠู‡
341
00:26:28,360 --> 00:26:31,340
reactionุŒ ู…ุงุญุตู„ุด ููŠู‡ damage ุจุฏูˆ ูŠูƒูˆู† ููŠู‡ no reaction
342
00:26:31,340 --> 00:26:36,000
ู…ุงุดูŠุŸ ุงู„ู„ูŠ ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ุฅู† ุงู„ู€ lymphocyte of donor
343
00:26:36,000 --> 00:26:40,180
and recipient ู‡ู… ุงู„ู„ูŠ ู†ูุณู‡ู… ุจู†ุนู…ู„ู‡ู… ู…ุน panel of
344
00:26:40,180 --> 00:26:44,720
antibody ููŠู‡ ุฏูˆู„ ุงู„ู„ูŠ ู‡ูˆ ูŠุนูŠุด ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€
345
00:26:44,720 --> 00:26:45,500
complement
346
00:26:49,160 --> 00:26:53,120
ุฒูŠ ู…ุง ู‚ู„ุช ุงู„ู€ code ูƒุงู…ู„ุฉ ู…ุง ู‡ุชุญุทูŠู‡ุงุด ูˆู‡ุชู†ุดุท ู„ู†ุง
347
00:26:53,120 --> 00:26:58,800
ุงู„ู„ูŠ ู‡ูˆ ู‡ุชุชู†ุดุท ู„ุฃู†ู‡ ููŠ ูˆุฌูˆุฏ antibody ู‡ูŠ ุจุชุณุงุนุฏ ู†ุดุงุท
348
00:26:58,800 --> 00:27:01,980
ูˆุจุชูƒูˆู† ู„ู‡ุง ุงู„ู€ memoryุŒ ู†ู‚ุทุฉ complex that will
349
00:27:01,980 --> 00:27:05,300
damage ุงู„ู€ target cellุŒ ูˆุจุงู„ุชุงู„ูŠ ุฅุฐุง ุตุงุฑ damaged
350
00:27:05,300 --> 00:27:08,400
ุงู„ู…ุนู†ู‰ ุชุบุทู‰ุŒ ุทุจุนุง ูƒู†ุง ู†ุนุฑู ุฅู†ู‡ ุตุงุฑ damaged ูˆู„ูˆ
351
00:27:08,400 --> 00:27:12,060
ู…ุงุตุงุฑุด damaged ู†ุณู…ูˆู‡ุŒ ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ุจุชุงุฎุฏ ุงู„ุตุจุบุฉ
352
00:27:12,060 --> 00:27:15,020
ุจุชูƒูˆู† ุญูŠุฉ ูˆุงู„ู„ูŠ ู…ุง ุจุชุงุฎุฏ ุงู„ุตุจุบุฉ ุจุชูƒูˆู† ู…ูŠุชุฉ
353
00:27:20,200 --> 00:27:28,400
ุงู„ุงุณู„ูˆุจ ุงู„ุขุฎุฑ ุฃูˆ ุงู„ู€ area ุงู„ุฃุฎุฑู‰ ุงู„ู„ูŠ ุจู†ูุญุต
354
00:27:28,400 --> 00:27:31,320
ููŠู‡ุง ุงู„ู€ MHC molecule ู‡ูˆ by using molecular
355
00:27:31,320 --> 00:27:39,820
techniqueุŒ and PCR isุŒ ููŠ ู…ุตุฑ ุฃุนุชู‚ุฏ ุฅู†ู‡ Mixed Leukocyte
356
00:27:39,820 --> 00:27:46,260
reactionุŒ ู…ุงู‡ูŠ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ุงุŸ ุจู†ุญุท ุงู„ู€ leukocyte of
357
00:27:46,260 --> 00:27:49,600
ุงู„ู€ Donor ูˆุงู„ู€ Recipient ู…ุน ุจุนุถ ูˆุจู†ุนู…ู„ู‡ู… culture
358
00:27:49,600 --> 00:27:54,920
for several daysุŒ ุทุจุนุง ุงู„ู€ Donor T cell respond to
359
00:27:54,920 --> 00:27:59,540
ุงู„ู€ MHC molecule ุจุชู†ุดุท ุฃูˆ expressed on the
360
00:27:59,540 --> 00:27:59,940
Recipient
361
00:28:04,920 --> 00:28:08,400
ุณูŠูุฑุฒ ุงู„ู€ Cytokine ูˆุณูŠู‚ูˆู… ุงู„ู€ Cytokine ุจุฅุฏุฎุงู„ ุงู„ู€
362
00:28:08,400 --> 00:28:15,060
proliferationุŒ ุงู„ู‚ูŠุงุณ ู„ู„ู€ Proliferation ู‡ูˆ ู…ู† ูŠุญุฏุฏ
363
00:28:15,060 --> 00:28:21,460
ุทุจุนุง ุฅุฐุง ูƒุงู† ููŠู‡ reaction positive ุฃูˆ reaction
364
00:28:21,460 --> 00:28:24,140
negativeุŒ ูˆูŠู…ูƒู† ุฃู† ูŠุชู… ู…ุฌุฑุฏู‡ ุจุณู‡ูˆู„ุฉ ู…ู† ุฎู„ุงู„ ุชุณุฌูŠู„
365
00:28:24,140 --> 00:28:26,880
ุงู„ุฑุงุฏูŠูˆ ุฅู„ู‰ ู…ุฌุงู„ ุงู„ุชุนู„ูŠู…
366
00:28:30,400 --> 00:28:34,840
ุทุจุนุง ู‡ู†ุง ุญุงู„ุงุช of Mixed Lymphocyte reaction
367
00:28:34,840 --> 00:28:38,060
associated with different transplantation
368
00:28:38,060 --> 00:28:42,700
situationุŒ ุทุจุนุง ู…ุฌู…ูˆุนุฉ ู…ุฎุชู„ูุฉ ูˆุฅูŠุด ุจูŠุตูŠุฑ ููŠ ูƒู„ ุญุงู„ุฉ
369
00:28:43,270 --> 00:28:47,870
ูˆุทุจุนุง ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† ู…ุซุงู„ ุงู„ุฃูˆู„ tissue between
370
00:28:47,870 --> 00:28:52,570
identical twinsุŒ ุงู„ุนู„ุงู‚ุฉ they are syngenicุŒ ุนู…ู„ู†ุง
371
00:28:52,570 --> 00:28:55,830
ู„ู‡ู… ุฃุดูŠุงุก ู‚ุงู„ูˆุง ู„ุฃ no treatment for the cells
372
00:28:55,830 --> 00:29:00,570
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู€ Mixed Lymphocyte reaction will be
373
00:29:00,570 --> 00:29:05,290
negativeุŒ ู…ุงููŠุด ุชูุงุนู„ ูŠุนู†ูŠ no proliferationุŒ ู…ุงุดูŠ
374
00:29:05,290 --> 00:29:09,650
ูุงู„ุชุงู†ูŠ ู†ูุณ ุงู„ุญูƒุงูŠุฉ tissue between non-related
375
00:29:09,650 --> 00:29:13,380
donor and recipientุŒ ู…ุนู†ุงู‡ ู„ุง ุดูŠุก ู„ูƒู† ููŠู‡ reaction
376
00:29:13,380 --> 00:29:18,600
ู„ู…ุงุฐุงุŸ ู„ุฃู†ู‡ ุตุงุฑ ููŠู‡ recognition ู„ู€ foreign MHC
377
00:29:18,600 --> 00:29:22,740
molecule ู…ู† ุฎู„ุงู„ host ุฃูˆ donor cell ูˆุจุงู„ุชุงู„ูŠ ุตุงุฑ
378
00:29:22,740 --> 00:29:27,940
ููŠู‡ proliferative capacity ู„ู„ู€ tissue ุจูŠู†
379
00:29:27,940 --> 00:29:32,920
unrelated donor and recipient ุดูˆ ุนู…ู„ูˆุงุŸ ู‚ุงู„ูˆุง ุทุจุนุง
380
00:29:32,920 --> 00:29:36,860
actually is different ูˆุจุงู„ุชุงู„ูŠ ุจุชุนุชุจุฑ ุฃู„ูˆุฌูŠู†ูŠูƒ ุทุจ
381
00:29:36,860 --> 00:29:44,070
ุฅูŠู‡ ุดูˆ ุนู…ู„ูˆุงุŸ ู‚ุงู„ูˆุง donor cell ุนุงู…ู„ูŠู†ู‡ุง ู…ุงุดูŠ mitotic
382
00:29:44,070 --> 00:29:50,630
inhibitor ูŠุนู†ูŠ ุณูƒุชูˆู‡ุง ูŠุนู†ูŠ ู…ุง ุจุฏู‡ุงุด ูŠุงูƒูŠุด ุชุชู†ุดุท
383
00:29:50,630 --> 00:29:54,930
ุทุจ ู‡ุงุด ู…ุฌุจูˆุถ ู‡ุงุด ุจูŠุนู†ูŠ ุจูŠุจู‚ู‰ ูŠุนู†ูŠ ู„ุฃู†ู‡ ู†ุณุชุฎุฏู… ุงู„ู€
384
00:29:54,930 --> 00:29:57,750
antigen ุชุจุนู‡ุง ุทุจ ู…ูŠู† ุงู„ู„ูŠ ุจุฏู‡ ูŠุชู†ุดุท ุฏู„ูˆู‚ุชุŸ ุงู„ู€
385
00:29:57,750 --> 00:30:00,670
recipient cell ู‡ูŠ ุงู„ู„ูŠ ู‡ุชุชู†ุดุท ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ
386
00:30:00,670 --> 00:30:05,350
ูุจุงู„ุชุงู„ูŠ ู‡ูˆ one way mixed lymphocyte reaction ู…ู†
387
00:30:05,350 --> 00:30:09,510
ุงุชู†ุดุท ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„ู€ donor cell ุฃูˆ ุงู„ู€ recipient
388
00:30:09,510 --> 00:30:16,270
cell ุทุจุนุง ููŠ ุงู„ุญุงู„ุฉ ุงู„ุฑู‚ู… 4 ุงู„ุนูƒุณ ุตุญูŠุญ ุงุญู†ุง ูˆู‚ูู†ุง
389
00:30:16,270 --> 00:30:20,290
ุงู„ู€ recipient cell ูˆู†ุดุทู†ุง ุงู„ู€ donor cell
390
00:30:20,290 --> 00:30:23,390
prolongation
391
00:30:23,390 --> 00:30:28,190
of allograft survival can be achieved by
392
00:30:28,190 --> 00:30:32,790
immunosuppressive therapy ูุงู„ู€ Immunosuppressive
393
00:30:32,790 --> 00:30:36,590
Therapy ู…ุงุฐุง ุจุชุนู…ู„ุŸ ุฌุง ู„ู‡ุง ุชุทูˆุฑ ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
394
00:30:36,590 --> 00:30:38,150
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
395
00:30:38,150 --> 00:30:39,270
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
396
00:30:39,270 --> 00:30:40,750
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
397
00:30:40,750 --> 00:30:42,630
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
398
00:30:42,630 --> 00:30:43,610
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
399
00:30:43,610 --> 00:30:43,850
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
400
00:30:43,850 --> 00:30:49,590
ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู… ุงู„ุงุณู…
401
00:30:49,590 --> 00:30:56,990
ุงู„ุงุณู… ุงู„ุงุณู…
402
00:30:56,990 --> 00:31:00,990
ุฌุง ู„ู‡ุง ุนุจุงุฑุฉ ุนู† combination of synergistic
403
00:31:00,990 --> 00:31:07,190
immunosuppressive drug ุชู†ูŠู† ุชู†ูŠู† ุจุชุณุงุนุฏู‡ ุดูˆ
404
00:31:07,190 --> 00:31:09,750
ุจูŠุนู…ู„ูˆุงุŸ ุฌุง ู„ู‡ุง they interfere with the immune
405
00:31:09,750 --> 00:31:14,550
response mechanism ุฒูŠ ุฅูŠุดุŸ ุฒูŠ ุงู„ู€ T cell activation
406
00:31:14,550 --> 00:31:22,750
drug doses are lower than the induction therapy ุฒูŠ
407
00:31:22,750 --> 00:31:27,290
ุฃู‚ู„ ู…ู† ุงู„ู„ูŠ ููˆู‚ ุชุณู…ุญ ู„ุดุฑูƒุฉ ุงู„ุงู†ุชุฌุงุฑ ุงู„ุงุณุงุณูŠ ู„ุชุนู…ู„
408
00:31:27,290 --> 00:31:30,910
ุนู„ู‰ ู…ุณุชูˆู‰ ุนุงู„ูŠ ูˆุจุงู„ุชุงู„ูŠ ุชู‚ู„ู„ ุงู„ุงู†ุณุฏุงู†ุณ ู„ู„ุฅู†ูุงู‚ุงุช
409
00:31:30,910 --> 00:31:35,910
ุงู„ูˆุงุฑุชุดูˆู†ูŠุณุชูŠูƒูŠุฉ ู…ุงุดูŠ ุจู‚ู‰ ููŠ ุญุงุฌุฉ ุงุณู…ู‡ุง induction
410
00:31:35,910 --> 00:31:38,790
therapy ูˆููŠ ุญุงุฌุฉ ุงุณู…ู‡ุง maintenance therapy ุงู„ู€
411
00:31:38,790 --> 00:31:41,330
induction therapy ุจุชุจู‚ู‰ ุชุฌุงุฑุจ ุงู„ู€ transplantation
412
00:31:41,330 --> 00:31:46,870
ูุชุฑุฉ ุงู„ู€ maintenance therapy two drugs or more they
413
00:31:46,870 --> 00:31:50,470
are synergistic ุงู…ูŠู†ูˆ ุณุงุจุฑุณ ุงู„ู€ drug ุงู„ุงุชู†ูŠู†
414
00:31:50,470 --> 00:31:54,800
ุจูŠุดุชุบู„ูˆุง ุนู„ู‰ ุงู„ุชูŠู„ูŠููˆุณุงูŠุช ุจูŠู‚ู„ู„ูˆุง ุฃูˆ ุจูŠุจุทุคูˆุง ู‡ูŠ
415
00:31:54,800 --> 00:32:01,620
ุชุฎู„ุต ุชุฌุงุฑุจ ุงู„ุฅูŠู…ูŠูˆู† ูˆุจุงู„ุชุงู„ูŠ ุชู‚ู„ู„ ุชุฌุงุฑุจ ุงู„ุฅู†ููƒุดู†
416
00:32:01,620 --> 00:32:10,620
ููŠ ุจุนุถ ุงู„ุญุงู„ุงุช
417
00:32:10,620 --> 00:32:16,440
ูŠุชู… ุฅุนุทุงุก ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ
418
00:32:16,440 --> 00:32:18,840
ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ
419
00:32:18,840 --> 00:32:18,900
ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ
420
00:32:18,900 --> 00:32:18,980
ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ
421
00:32:18,980 --> 00:32:21,510
ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุชุฌุงุฑุจ ุงู„ุชูŠ ุชุณุชุฎุฏู…
422
00:32:21,510 --> 00:32:25,510
ููŠ ู…ุณุชูˆู‰ ู…ุดุงุจู‡ ู„ู„ุฐู„ูƒ ููŠ ู…ุณุชูˆู‰ ุงู„ู€ ุงู†ุฏูˆูƒุดู† ุซูŠุฑุงุจูŠ
423
00:32:25,510 --> 00:32:30,830
ู…ู†ู‡ุง ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงู„ู€ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ ุงู†ุชูŠ
424
00:32:30,830 --> 00:32:35,610
ุงู†ูู„ุงู…ุงุชูˆุฑูŠ ุฃูŠ ุฌู†ุณ ุฃูˆ ู…ุซุงู„ ุนู„ู‰ ุฐู„ูƒ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ
425
00:32:35,610 --> 00:32:41,110
ุฃูˆ ุจุฑุฏู†ุฒูˆู„ูˆู† ุฃูˆ ู…ุซุงู„ ุจุฑุฏู†ุฒูˆู„ูˆู† ูƒู„ ุนุจุงุฑุฉ ุนู† ุฃุณู…ุงุก
426
00:32:41,110 --> 00:32:46,590
ู„ู†ูุณ ุงู„ู…ุฑูƒุจ ู…ุงุฐุง ูุนู„ ุงู„ู€ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏุฒุŸ ู‚ุงู„ูˆุง ุฅู†ู‡
427
00:32:46,590 --> 00:32:49,210
ุณูŠู‚ูˆู… ุจุชุญุฑูŠูƒ ุงู„ู€ ู‡ูˆุงุฑุงู†ูŠู…ูŠู†ูˆ ุณุงุจุฑูŠุณ ุงู„ู€ ู‡ูˆุงุฑุงู†ูŠู…ูŠู†ูˆ
428
00:32:49,210 --> 00:32:56,290
ุณุงุจุฑูŠุณ ุงู„ู€ ู‡ูˆุงุฑุงู†ูŠู…ูŠู†ูˆ
429
00:32:59,020 --> 00:33:02,340
ุงู„ู€ ุฌูŠู†ุงุช ู‡ุฐู‡ ุจุชุดุชุฑูƒ ุฃู†ู‡ุง ุชู‚ูˆู… ุจุชุดุชุฑูƒ ุงู†ูู„ุงู…ุงุชูˆุฑูŠ
430
00:33:02,340 --> 00:33:07,680
ุณุงูŠุชูˆูƒุงูŠู† ู…ู†ู‡ุง ุงู„ู€ I L 1 ูˆ 2 ูˆ 3 ูˆ 4 ูˆ 5 ูˆ 8 Human
431
00:33:07,680 --> 00:33:14,080
Necrosis Factor Alpha GM CSF ุจู†ูˆู‚ู ุงู„ู€ ุฌูŠู†ุงุช ุงู„ู„ูŠ
432
00:33:14,080 --> 00:33:19,820
ุจุชุนู…ู„ expression for the cytokine ูˆุจุงู„ุชุงู„ูŠ it's an
433
00:33:19,820 --> 00:33:22,780
immunosuppressive
434
00:33:24,090 --> 00:33:26,910
ู…ุงุฐุง ูŠูุนู„ ุฃูŠุถู‹ุงุŸ ู‚ุงู„ ุฅู† ุงู„ู€ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ ุฃูŠุถู‹ุง
435
00:33:26,910 --> 00:33:30,330
ูŠู…ูƒู† ุงู†ู‡ูŠุจุท ุฅุธู‡ุงุฑ ู…ูˆู„ูŠูƒูˆู„ุงุช ุงู„ู€ ุงุฏู‡ูŠุฌูŠุง. ุทุจ ูˆุฅูŠุด
436
00:33:30,330 --> 00:33:33,830
ูŠุนู†ูŠ ู„ู…ุง ู†ุนู…ู„ ุฅุธู‡ุงุฑ ู…ูˆู„ูŠูƒูˆู„ุงุช ุงู„ู€ ุงุฏู‡ูŠุฌูŠุงุŸ ู‚ุงู„ ุฅู†ู‡
437
00:33:33,830 --> 00:33:39,010
ุณูŠู†ู‡ูŠุจุท ุชุญูˆูŠู„ ุงู„ู€ ู„ูŠูƒูˆุณูŠุช. ุฃูŠู† ุจุชุฑูˆุญ ุงู„ู€ ู„ูŠูƒูˆุณูŠุชุŸ ุฅู„ู‰
438
00:33:39,010 --> 00:33:42,430
ู…ูˆู‚ุน ุงู„ุงู†ููƒุงุด ุฃูˆ ุงู„ุงู†ูู„ุงู…ุด. ูˆุจุงู„ุชุงู„ูŠ
439
00:33:42,430 --> 00:33:49,470
ุงู„ู€ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ ูŠู†ู‡ูŠุจุท ุนู…ู„ูŠุฉ ุชุญูˆูŠู„ ุงู„ู€ ู„ูŠูƒูˆุณูŠุช. ุทูŠุจ
440
00:33:49,470 --> 00:33:52,370
ุฅูŠุด ูƒู…ุงู† ุจุชุนู…ู„ุŸ ู‚ุงู„ ุฅู†ู‡ู… ูŠุฏุนู…ูˆุง ุฅุทู„ุงู‚ ุณู„ุฑ
441
00:33:52,370 --> 00:33:56,540
ุงู„ุงู†ุฏูˆู†ูŠูƒู„ูŠุงุฒูŠ. ูˆู‡ุฐุง ุจูŠุคุฏูŠ ุฅู„ู‰ induction of
442
00:33:56,540 --> 00:34:01,520
apoptosis ููŠ ุงู„ู€ limphocyte ูˆุงู„ุงูŠุฒูŠู†ูˆููŠู„ ูŠุนู†ูŠ ุงู„ู€
443
00:34:01,520 --> 00:34:03,940
limphocyte ูˆุงู„ุงูŠุฒูŠู†ูˆููŠู„ ุงู„ู„ูŠ ุจุฏู‡ู… ูŠุนู…ู„ูˆุง immune
444
00:34:03,940 --> 00:34:08,580
response ุจูŠู‚ูˆู„ูˆุง ู‡ูˆ ุณูƒุชุฑูˆุง in addition they
445
00:34:08,580 --> 00:34:11,840
reduced phagocytosis ุทุจ ุฃู†ุง ููˆุฌ ุนู…ู„ุช inhibition ู„ู€
446
00:34:11,840 --> 00:34:16,220
ู„ูŠูƒูˆุณุงูŠุช migration ูˆุจุงู„ุชุงู„ูŠ I reduced the
447
00:34:16,220 --> 00:34:18,560
phagocytosis and killing by neutrophil and
448
00:34:18,560 --> 00:34:22,000
macrophages and reduced expression of MSC class 2
449
00:34:22,000 --> 00:34:27,320
molecule ุจู‡ุฐู‡ ุงู„ุทุฑูŠู‚ุฉ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ ู†ู‡ูŠุจ ุงู„ู€ T
450
00:34:27,320 --> 00:34:32,180
-cell activation ูˆ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
451
00:34:32,180 --> 00:34:34,820
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
452
00:34:34,820 --> 00:34:35,260
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
453
00:34:35,260 --> 00:34:36,340
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
454
00:34:36,340 --> 00:34:39,180
ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„ ุชุนู…ู„
455
00:34:53,710 --> 00:34:58,890
ูˆุจุนู…ู„ ุงู†ู‡ูŠุจุดูŠู† ุงู†ูˆุณูŠู†ูƒ
456
00:34:58,890 --> 00:35:17,130
ุงุณุฏ ุงู†ู‡ูŠุจุดูŠู†
457
00:35:17,130 --> 00:35:22,910
ุงู†ูˆุณูŠู†ูƒ ุงุณุฏ ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู†
458
00:35:22,910 --> 00:35:22,970
ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู†
459
00:35:22,970 --> 00:35:23,550
ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู†
460
00:35:23,550 --> 00:35:23,570
ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู†
461
00:35:23,570 --> 00:35:27,530
ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† ุงู†ู‡ูŠุจุดูŠู† of Purine Clorampucil
462
00:35:27,530 --> 00:35:33,650
and cyclophosphamide ุงู„ูƒู„ูŠุช DNA ู‡ุฐูˆู„ู‡ ุนุจุงุฑุฉ ุนู†
463
00:35:33,650 --> 00:35:37,370
cytotoxic drug ุชู†ูŠู† ุชุงู†ูŠู† ูˆุจุฑุถู‡ ู…ุดู‡ูˆุฑูŠู† ููŠ
464
00:35:37,370 --> 00:35:40,910
ุงู„ุงุณุชุฎุฏุงู… ุดูˆ ุจูŠุนู…ู„ูˆุงุŸ ุจูŠุนู…ู„ูˆุง ุงู„ูƒู„ูŠุชุดู† ู„ู€ DNA
465
00:35:40,910 --> 00:35:48,600
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุชุฏุฎู„ูˆุง ููŠ ุงู„ู€ metabolism of DNA ูƒุงู†ุช
466
00:35:48,600 --> 00:35:52,400
ุชุชุทูˆุฑ ุฃูˆู„ุงู‹ ู„ุชุนุงู…ู„ ุจุงู„ูƒุงู†ุณุฑ ููŠ ุงู„ุฃุณุงุณ ุนุจุงุฑุฉ ุนู†
467
00:35:52,400 --> 00:35:57,920
ูƒูŠู…ูˆุซูŠุฑุงุจูŠ ูˆ ู‡ู… ุฃูŠุถุงู‹ ุตูŠุฏูˆุชูƒุณูŠูƒ ู„ู„ู…ููˆุณุงูŠุฏ ูˆ
468
00:35:57,920 --> 00:36:03,320
ุจูŠุณุชุฎุฏู…ู‡ู… ูƒู…ูŠูˆู†ูˆ ุณุจุฑูŠุณูŠุจ ุงูŠุฌุงู†ุช ู…ู† ู…ุง ุงุนุชุจุฑุช
469
00:36:03,320 --> 00:36:08,400
ุงูŠุฌุงู†ุช ุชุชุนุงู…ู„ ู…ุน ุตูŠุฏูˆุชูƒุณูŠูƒุงูŠู† production ูˆ
470
00:36:08,400 --> 00:36:14,220
signaling ู…ู†ู‡ุง ุณุงูŠูƒู„ูˆุณุจูˆุฑูŠู† ูˆ ุงู„ุชุงูƒุฑูˆ
471
00:36:17,530 --> 00:36:20,410
ู…ุงุฐุง ูŠูุนู„ุŸ ูŠูุนู„ ุฃู†ู‡ ูŠุชุนุงู…ู„ ุจุงู„ู€ Calcium Urine
472
00:36:20,410 --> 00:36:27,890
ุจุฑุชุจุชู‡ ุจุงู„ู€ Immunophilins ุจูŠู‡ ูˆู‡ูˆ ุนุจุงุฑุฉ ุนู† family
473
00:36:27,890 --> 00:36:31,210
of intracellular protein ุชู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ู€
474
00:36:31,210 --> 00:36:35,490
lymphocyte signaling pathway ูˆุจุงู„ุชุงู„ูŠ ุจุชุนู…ู„ Signal
475
00:36:35,490 --> 00:36:41,990
Transduction Pathway Inhibition ู…ุงุดูŠ ูˆุฅุฐุง ู…ุง ุตุงุฑุด
476
00:36:41,990 --> 00:36:46,290
ููŠู‡ Signal Transduction ู…ุงููŠุด function ุจุงู„ุฅุถุงูุฉ ู„ุฃู†
477
00:36:46,290 --> 00:36:50,590
ุงู„ู€ Cyclosporin ุชุฏูุน ู…ุนุฑูุฉ ุชุบูŠูŠุฑ ุงู„ูˆุถุน ุจูŠุทุง ูˆุฏู‡
478
00:36:50,590 --> 00:36:54,850
ุนุจุงุฑุฉ ุนู† ุงู†ู‡ูŠุจูˆุชูˆุฑูŠู‡ ุณุงูŠุชูˆูƒุงูŠู†ูˆ Cyclosporin ุฃูŠุถู‹ุง
479
00:36:54,850 --> 00:37:02,270
ู‡ูˆ ู…ููŠุฏ ุนู†ุฏู…ุง ูŠุชู… ุชุฏูุนู‡ ู‚ุจู„ ุงู„ุชุฏูุน ู„ูƒู†ู‡ ุบูŠุฑ ู…ููŠุฏ
480
00:37:02,270 --> 00:37:06,850
ููŠ ุฅุบู„ุงู‚ ุฅุชุฌุงุฑ ู…ุณุชู…ุฑ ูŠุนู†ูŠ ุฅุฐุง ุฅุชุฌุงุฑ ุดุบุงู„ุŒ ุฅูŠู‡
481
00:37:06,850 --> 00:37:12,690
ุจูŠู‚ูˆู„ุชู‡ุŸ Cyclosporin ุจูŠุนุชุจุฑ ู†ูุฑูˆุชูˆูƒุณูŠูƒ ูˆุจุงู„ุชุงู„ูŠ
482
00:37:12,690 --> 00:37:17,520
ุจูŠุฒูŠุฏ ุงู„ู€ risk of cancer when administered for long
483
00:37:17,520 --> 00:37:22,960
term ูŠุนู†ูŠ ุฅุฐุง ุงุชุฎุฐ ู„ูุชุฑุงุช ุทูˆูŠู„ุฉ ู…ู…ูƒู† ูŠุนู…ู„ ูŠูƒูˆู†
484
00:37:22,960 --> 00:37:28,340
tumorigenesis ู†ุจุฑ ุฃุฑุจุน immunosuppressive antibody
485
00:37:28,340 --> 00:37:31,380
therapy ุจูŠุนุทูˆุง Anti lymphocyte antibody
486
00:37:31,380 --> 00:37:36,320
preparation ุฒูŠ as horse and rabbit anti lymphocyte
487
00:37:36,320 --> 00:37:45,280
globulin ุงุณุชุฎุฏู…ูˆู‡ู… as immunosuppressive therapy ุจุณ
488
00:37:45,280 --> 00:37:48,480
ู„ู„ู…ุคุณู ู…ู…ูƒู† ูŠุนู…ู„ูˆุง serum sickness disease ูŠุนู†ูŠ ุงู„ู€
489
00:37:48,480 --> 00:37:52,420
complications ุชุจุนุชู‡ู… ุฃู†ู‡ ู…ู…ูƒู† ูŠุตูŠุฑ serum sickness
490
00:37:52,420 --> 00:37:57,740
monoclonal antibody and engineered mouse human
491
00:37:57,740 --> 00:38:02,020
chimeric antibody ุฃูˆ ุจูŠุณู…ูˆู‡ humanized antibody
492
00:38:02,020 --> 00:38:08,220
ุงุณุชุฎุฏู…ูˆู‡ู… ุฒูŠ ุงู„ู€ RKT3 which is directed at KSCD3
493
00:38:08,220 --> 00:38:10,940
ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ ุงู„ู€ T lymphocytes
494
00:38:14,360 --> 00:38:21,740
ุงู„ู€ Zamab ูˆ Bacillus Zamab ู‡ู… ู…ุญุฏุซูŠู† ู„ู€ IL-2
495
00:38:21,740 --> 00:38:26,940
ุฑูŠุณูŠุจุชูˆุฑ Alpha-Chain ุงู„ู„ูŠ ู‡ูˆ CD25 ูˆูŠุนู…ู„ูˆู† ุฅุนุงุฏุฉ
496
00:38:26,940 --> 00:38:30,400
ุฅุนุงุฏุฉ ุฅุนุงุฏุฉ ุฅุนุงุฏุฉ ุงู„ุฅุนุงุฏุฉ ุงู„ุฑูŠุณูŠุจุชูˆุฑ IL-2 ุนู„ู‰ ุณุทุญ
497
00:38:30,400 --> 00:38:34,440
ุงู„ู€ T-Lymphocytes. ู‡ุคู„ุงุก ู‡ู… ู…ุฎู„ูˆู‚ุงุช ุฅุนุงุฏุฉ ุฅุนุงุฏุฉ
498
00:38:34,440 --> 00:38:37,860
ุฅุนุงุฏุฉ CD3 ูˆุฅุนุงุฏุฉ ุฅุนุงุฏุฉ CD25
499
00:38:40,900 --> 00:38:45,420
ุงู„ู€ IL-2 ูˆุงู„ุงูƒุชูุงุกุงุช
500
00:38:45,420 --> 00:38:55,940
ุงู„ุชุงุจุนุฉ ู„ู„ู€ T-cell. ู„ุง ู†ู†ุณู‰ ุฃู† ู‡ู†ุงูƒ ุงู‚ุชุฑุงุญุงุช ุชุชุฌู‡
501
00:38:55,940 --> 00:39:03,420
ุฅู„ู‰ ุงู„ู€ T-Helper-17 ุฃูˆ T-Helper-1. ูˆุงู„ุจุนุถ
502
00:39:03,420 --> 00:39:07,960
ู…ู† ุงู„ู€ T-Reg Cell ู‚ุฏ ูŠูƒูˆู† ู…ุณุฆูˆู„ู‹ุง ู„ุฅู†ู‚ุงุฐ ุนุถูˆูŠุฉ ู…ู†
503
00:39:07,960 --> 00:39:12,410
ุงู„ุงู†ุชุฌุงุฑ ุงู„ุนุถูˆูŠ. ุทุจุนู‹ุง ู…ุง ุงุญู†ุง ุนุงุฑููŠู† ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ
504
00:39:12,410 --> 00:39:16,870
ุณูˆุงุก ูƒุงู† ุชูŠุฑุจุฑ ูˆุงุญุฏ ุฃูˆ ุชูŠุฑุจุฑ ุณุจู†ุชูŠู† ุฅุฐุง ูƒุงู† ู…ุดูŠู†ุง
505
00:39:16,870 --> 00:39:19,950
ููŠ ู‡ุฐู‡ ุงู„ู…ูŠูƒุงู†ูŠุฒู…ุงุช ูˆุงุญุฏ ู†ุดุท ู†ูŠูˆุชุฑูˆููŠู„ ูˆุงุญุฏ ู†ุดุท
506
00:39:19,950 --> 00:39:23,070
ู…ุงูƒุฑูˆููŠุฑ ูˆุจุงู„ุชุงู„ูŠ ู…ู…ูƒู† ูŠุนู…ู„ูˆุง acute graft
507
00:39:23,070 --> 00:39:31,550
rejection ุจู„ู‚ูˆุง K-cytokines in vivo ุฃุดู‡ุฑู‡ุง IL-6
508
00:39:31,550 --> 00:39:38,730
ู‡ุฐุง ู…ู…ูƒู† ูŠุนู…ู„ shifting from ุชูŠุฑุจุฑ 17 ู„ู€ T-reg
509
00:39:38,730 --> 00:39:47,490
T-reg
510
00:39:47,490 --> 00:39:50,470
T-reg T-reg T-reg T-reg T-reg T-reg T-reg T-reg
511
00:39:50,470 --> 00:39:50,490
T-reg T-reg T-reg T-reg T-reg T-reg T-reg T-reg
512
00:39:50,490 --> 00:39:50,650
T-reg T-reg T-reg T-reg T-reg T-reg T-reg T-reg
513
00:39:50,650 --> 00:39:51,910
T-reg T-reg T-reg T-reg T-reg T-reg T-reg T-reg
514
00:39:51,910 --> 00:40:00,250
T-reg T-reg T-reg T-reg T-reg T-reg Plucking ุจูŠุนู…ู„ูˆุง
515
00:40:00,250 --> 00:40:05,410
Plucking ู„ู„ู€ IL-6 ูˆู‡ุฐุง ุจูŠุญูˆู„ ู…ู† T-Helper cell 17
516
00:40:05,410 --> 00:40:12,550
Activity ู„ู€ T-Reg Activity ุจูŠุฌูŠ ู„ู„ุชุทุจูŠู‚
517
00:40:12,550 --> 00:40:17,870
ุงู„ู‡ูŠูˆุบุฑูˆุจูˆุชูŠูƒ stem cell Transplantation ูˆู‡ุฐุง
518
00:40:17,870 --> 00:40:23,430
ุจูŠุชูƒูˆูŠู† ู…ู† Special Transplantation Situation ุงู„ุชูŠ
519
00:40:23,430 --> 00:40:27,470
ุชุชุฌุงุฑุจ ุนุงู…ุฉ ุจูŠู† ู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
520
00:40:27,470 --> 00:40:28,850
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
521
00:40:28,850 --> 00:40:30,650
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
522
00:40:30,650 --> 00:40:38,170
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
523
00:40:38,170 --> 00:40:40,030
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
524
00:40:40,030 --> 00:40:40,950
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
525
00:40:40,950 --> 00:40:44,690
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ
526
00:40:44,690 --> 00:40:46,650
ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎุฏู… ุงู…ูŠู†ูˆ ูƒูˆู…ุจุชุงู† ูˆู…ุณุชุฎ
527
00:40:49,670 --> 00:40:58,830
stem cell ู…ู† ุงู„ู€ blood ุณูˆุงุก ูƒุงู† blood ู…ู† ุงู„ู„ูŠ ู‡ูˆ
528
00:40:58,830 --> 00:41:06,690
ุนูŠู†ุฉ ุนุงุฏูŠุฉ ุฃูˆ
529
00:41:06,690 --> 00:41:11,110
ุงู„ู…ู‡ู… ุงู„ู€ stem cell ุจุชุชุงุฎุฏ Hematopoietic stem cell is
530
00:41:11,110 --> 00:41:14,090
used to treat a variety of conditions ุจู…ุง ููŠู‡ุง
531
00:41:14,090 --> 00:41:19,640
SCID ุงู„ู„ูŠ ู‡ูˆ Severe Combined Immunodeficiency ูˆ Wiscott
532
00:41:19,640 --> 00:41:28,020
Aldrich Syndrome ูˆุงู„ู„ูˆูƒูŠู…ูŠุง ุงู„ู…ุชุนุงู…ู„ุฉ ุจุดูƒู„
533
00:41:28,020 --> 00:41:29,440
ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„
534
00:41:29,440 --> 00:41:29,720
ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„
535
00:41:29,720 --> 00:41:29,740
ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„
536
00:41:29,740 --> 00:41:35,880
ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„ ูƒุงู…ู„ ุจุดูƒู„
537
00:41:35,880 --> 00:41:38,700
ูƒุงู…ู„ ุจุดูƒู„
538
00:41:45,720 --> 00:41:48,900
transplantation is a form of gene therapy ูˆูƒุฃู†
539
00:41:48,900 --> 00:41:52,980
ุงุญู†ุง ุจู†ุบูŠุฑ ุงู„ู€ gene ุงู„ู€ genetically abnormal blood
540
00:41:52,980 --> 00:41:56,840
forming stem cell are replaced by normally
541
00:41:56,840 --> 00:42:00,620
functioning cell ูƒู„ ุงู„ู„ูŠ ุจู†ุนู…ู„ู‡ ุฃู†ู‡ ุจู†ุบูŠุฑู‡ ุจู†ุง
542
00:42:00,620 --> 00:42:04,660
stem cell ู…ุฑูŠุถุฉ ูˆู†ุญุท ุจุฏู„ู‡ุง stem cell ุณู„ูŠู…ุฉ
543
00:42:04,660 --> 00:42:09,160
ultimate goal of hematopoietic cell transplantation
544
00:42:09,160 --> 00:42:15,160
ุฃู†ู‡ ู†ุฑุฌุน ุงู„ู€ Bone marrow ุฃูˆ ุงู„ู€ Hemopoiesis into its
545
00:42:15,160 --> 00:42:21,360
normal function ุงู„ูŠูˆู… Hematopoietic stem cell give
546
00:42:21,360 --> 00:42:24,300
rise to all blood cell lineage ุฒูŠ ู…ุง ุงุญู†ุง ุนุงุฑููŠู†
547
00:42:24,300 --> 00:42:28,820
Small number of these pluripotent cell also
548
00:42:28,820 --> 00:42:34,660
circulate in blood ูุทุจุนู‹ุง ุฃุซู†ุงุก ู‡ุฐู‡ ุงู„ุนู…ู„ูŠุฉ GCSF is
549
00:42:34,660 --> 00:42:38,360
used ุนุดุงู† ู†ุฒูˆุฏ ุงู„ู€ number of hematopoietic stem cell
550
00:42:38,360 --> 00:42:45,020
in both marrow and blood ู…ู‚ุงุฑู†ุฉ ู…ู† ู‡ุฐู‡ ุงู„ุฌู„ุฏุงุช ูŠู…ูƒู†
551
00:42:45,020 --> 00:42:52,260
ุชุฌุงุฑุจู‡ุง ู…ู† ูˆุฌู‡ุฉ CD43-34. ุฌู„ุฏ ุณูŠู…ุฌุงู†ูŠูƒุณ ุชูŠู…ุณูŠู„ ู…ุฑุชุจุท
552
00:42:52,260 --> 00:42:57,480
ุจุงู„ุฎุทุฑ ุงู„ุฃุนู„ู‰ ุจุณุจุจ ู…ุดุงุจู‡ุชู‡ ุงู„ุฌูŠู†ูŠูƒูŠุฉ ุจูŠู† ุงู„ุฏูˆู†ุงุฑ
553
00:42:57,480 --> 00:43:01,440
ูˆุงู„ุฑุณุจูŠู„. Autologous Hematopoietic Cell
554
00:43:01,440 --> 00:43:06,800
Transplantation ู‡ูˆ ุชู‚ู†ูŠุงุช ุงู„ุญุตูˆู„ ุนู„ู‰ ุฃุณู„ูˆุจ ู…ู† ุงู„ุฏู…
555
00:43:06,800 --> 00:43:13,440
ุฃูˆ ุงู„ู…ุฑูˆุฑ ูˆุฅุนุงุฏุชู‡ ุฅู„ู‰ ู†ูุณ ุงู„ุดุฎุต ุทุจ ูŠุนู†ูŠ ุจู†ุงุฎุฏ ู…ู†
556
00:43:13,440 --> 00:43:17,520
ู†ูุณ ุงู„ุดุฎุต ูˆู†ุฏูŠู‡ ุทุจุนู‹ุง ู‡ุฐุง ุงู„ูƒู„ุงู… ูƒูŠู ูŠุตูŠุฑ ู†ุงุฎุฏู‡ุง ููŠ
557
00:43:17,520 --> 00:43:24,770
ูุชุฑุฉ ุงู„ุตุญุฉ ูˆู†ุญูˆุดู‡ุง ู„ู‡ ู„ุญูŠู† ุงู„ู…ุฑุถ ู‡ูˆ ุนุงุฏุฉู‹ ูŠุชุนุงู…ู„
558
00:43:24,770 --> 00:43:28,910
ุจุงู„ุทุจูŠุน ุจุดูƒู„ ู…ุงู„ูŠุฌู†ุณูŠ ู…ุซู„ ุงู„ู„ูˆูƒูŠู…ูŠุง ุงู„ุงู†ููˆู…ูŠุง
559
00:43:28,910 --> 00:43:35,470
ูˆุงู„ู…ูŠู„ูˆู…ุง ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุฌูŠู†ูŠูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ
560
00:43:35,470 --> 00:43:35,770
ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ
561
00:43:35,770 --> 00:43:36,310
ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ
562
00:43:36,310 --> 00:43:37,090
ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ
563
00:43:37,090 --> 00:43:40,530
ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ
564
00:43:40,530 --> 00:43:49,170
ุงู„ู‡ูŠูˆุจูŠุชูƒ ุงู„ู‡ูŠูˆุจูŠุชูƒ
565
00:43:55,880 --> 00:44:01,140
ุจุงู„ุชุงู„ูŠ ุฅุฐุง ูƒู†ุง ู†ุญูƒูŠ ุนู„ู‰ ู…ุฌู…ูˆุนุฉ ุฃูˆ ู…ุฌู…ูˆุนุฉ ู…ู†
566
00:44:01,140 --> 00:44:06,840
ุงู„ุจู„ุณุงู†ุชุง ู„ูˆ ุจูŠุณู…ูˆู‡ุง ุงู„ุงู…ุจู„ุงูŠูƒุงู„ ุงู„ู„ูŠ ู‡ูˆ blood
567
00:44:06,840 --> 00:44:14,120
blood blood blood blood blood blood blood blood
568
00:44:14,120 --> 00:44:19,120
blood blood blood blood
569
00:44:19,120 --> 00:44:19,360
blood blood blood blood blood blood blood blood
570
00:44:19,360 --> 00:44:20,080
blood blood blood blood blood blood blood blood
571
00:44:35,730 --> 00:44:40,550
ุฃูˆ ุงู„ุงู†ุชุฌูŠู†ุงุช ุงู„ู„ูŠ ุฏุฎู„ุช ุนู„ู‰ ุงู„ู€ donor cell ุชุนุฑู
572
00:44:40,550 --> 00:44:45,990
ุนู„ูŠู‡ุง ุงู„ู€ host cell ูˆุนู…ู„ุชู‡ุง rejection ูˆุจูŠุณู…ูˆู‡ ููŠ
573
00:44:45,990 --> 00:44:51,890
ู‡ุฐุง ุงู„ุญุงู„ุฉ ุงู„ู€ host ูŠุชู†ุดุท ุถุฏ ุงู„ู€ graft ุงู„ู„ูŠ ุฏุฎู„
574
00:44:51,890 --> 00:44:56,510
ุณู…ูˆู‡ุง host vs graft effect ุฃูˆ ุงู„ุนูƒุณ ุฃู†ู‡ ุงู„ู„ูŠ ุงู„ู€
575
00:44:56,510 --> 00:45:00,330
immune reaction of to the host ุฃู…ุง C-antigen ุจูŠ
576
00:45:00,330 --> 00:45:04,890
occur as graft vs host disease ู†ูุณ ุงู„ู€ graft ู‡ูˆ
577
00:45:04,890 --> 00:45:10,150
ุงู„ู„ูŠ ุงุดุชุบู„ ุนู„ู‰ ุงู„ู„ุงู…ู† ูŠู…ุง ุงู„ู€ recipient ูŠูƒูˆู†
578
00:45:10,150 --> 00:45:14,750
immunocompetent Immunorejection by host T cell is
579
00:45:14,750 --> 00:45:17,230
usually prevented by intensive immunosuppression
580
00:45:17,940 --> 00:45:21,780
ูŠุนู†ูŠ ุฅุฐุง ุญุตู„ ุงู„ู€ host vs graft disease ูƒู„ ู…ุง ู†ูุนู„ู‡
581
00:45:21,780 --> 00:45:25,240
ู‡ูˆ ู†ุนุทูŠู‡ immunosuppress ูุจู†ุณูƒุช ุงู„ู€ host cell ุถุฏ ุงู„ู€
582
00:45:25,240 --> 00:45:30,620
donor cell Patient with immunodeficiency disease
583
00:45:30,620 --> 00:45:34,680
ุฃูŠ SCID ู…ุง ุจูŠุญุชุงุฌูˆุง ุงู„ู€ induction therapy since
584
00:45:34,680 --> 00:45:39,300
there is no risk of rejection by host ุฅู„ุง to
585
00:45:39,300 --> 00:45:42,880
reduce the risk of graft vs host disease ุฅู„ุง
586
00:45:42,880 --> 00:45:47,230
ุงู„ู…ูˆุถูˆุน ุงู„ุซุงู†ูŠ ุงู„ู…ุฑุถูŠ ุงู„ุซุงู†ูŠ T-cells are eliminated
587
00:45:47,230 --> 00:45:55,350
ู…ู† ุงู„ุนูŠู†ุฉ from donor cell population ุฅู…ุง ุจุงุณุชุฎุฏุงู…
588
00:45:55,350 --> 00:45:59,670
monoclonal anti T-cell antibody and complement or
589
00:45:59,670 --> 00:46:07,410
irradiation. Graft-versus-host disease ูŠูˆู… ู…ูŠุณูŠุฑ
590
00:46:07,410 --> 00:46:11,190
ุทุจุนู‹ุง Hematopoietic cell transplantation from donor
591
00:46:12,220 --> 00:46:15,980
ุจุงู„ุทุจุน ุฃู†ุง ุฃุดุฑุช ู„ูŠู‡ Desperate Recipient Results in
592
00:46:15,980 --> 00:46:19,020
Rejection ุทุจูŠุนูŠ ุฌุฏู‹ุง ูŠูˆู… ุงู„ุชู†ุดุท ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ host
593
00:46:19,020 --> 00:46:23,540
cell ุงู„ู€ donor cell against host antigen ุจูŠุตูŠุฑ ููŠู‡
594
00:46:23,540 --> 00:46:26,820
graft versus host disease ุทุจุนู‹ุง ุณูˆุงุก ุฅู† ุงู„ู€ antigen
595
00:46:26,820 --> 00:46:31,240
ูƒุงู† major ุฃูˆ minor ุงุชุด ุงู†ุชุฌูŠู† ุงู„ู…ู‡ู… ููŠู‡ reaction
596
00:46:31,240 --> 00:46:35,880
graft versus host disease ูŠุชูƒุงู…ู† ู…ู† ุงู„ู€ minor
597
00:46:35,880 --> 00:46:40,530
competent lymphoid cell ุจุงู„ู†ุณุจุฉ ู„ู„ู†ุงุณ ุงู„ู„ูŠ ุงุชุนุฑู
598
00:46:40,530 --> 00:46:48,310
ุนู„ู‰ ุงู†ุชุฌูŠู†ุงุช ุงู„ู‡ูˆุณุช ู‡ู… ุงู„ู†ุงุณ
599
00:46:48,310 --> 00:46:57,210
ุงู„ู„ูŠ ุงุชุนุฑู ุนู„ู‰ ุงู†ุชุฌูŠู†ุงุช ุงู„ู‡ูˆุณุช ู‡ู…
600
00:46:57,210 --> 00:47:01,290
ุงู„ู†ุงุณ ุงู„ู„ูŠ ุงุชุนุฑู ุนู„ู‰ ุงู†ุชุฌูŠู†ุงุช ุงู„ู‡ูˆุณุช Radiation
601
00:47:01,290 --> 00:47:05,550
Therapy ุฃูˆ Chemotherapy ุงู„ู„ูŠ ุจุชุฎู„ูŠ ู…ู†ุงุนุชู‡ู… ู‚ู„ูŠู„ุฉ
602
00:47:05,550 --> 00:47:09,490
ุฃูˆ ู…ุนุฏูˆู…ุฉ ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ ุฅู…ูƒุงู†ูŠุฉ ู„ุนุฏูˆุซ ุงู„ู€
603
00:47:09,490 --> 00:47:13,490
graft-versus-host disease ู„ุฅู†ู‡ ู…ู…ูƒู† ุชุตูŠุฑ ุงู„ูƒู„ุงู…
604
00:47:13,490 --> 00:47:20,790
ู‡ุฐุง as acute ูˆุจูŠุชุดูƒู„ ู‡ุฐู‡ ููŠ 15% ู„ู€ 40% ู…ู† ุญุงู„ุฉ ุงู„ู€
605
00:47:20,790 --> 00:47:25,590
hemipietic cell transplantation ูˆููŠ ู‡ุฐุง ุงู„ุญู„
606
00:47:25,590 --> 00:47:33,010
ุงู„ู…ูˆุชู‰ ูˆุงู„ู€ morbidity is
607
00:47:33,010 --> 00:47:37,090
the major cause of morbidity after allogenic HCT
608
00:47:37,090 --> 00:47:42,650
ุงู„ู€ chronic ุจุชุดูƒู„ ุญูˆุงู„ูŠ 50% ู…ู† ุงู„ู…ุฑุถู‰ ู…ุงุดูŠ ุจูŠุตูŠุฑ
609
00:47:42,650 --> 00:47:46,350
ููŠ ุญูˆุงู„ูŠ 50% ู…ู† ุงู„ู…ุฑุถู‰ ุงู„ู„ูŠ ู…ู…ูƒู† ูŠุซุจุช ู„ุบุงูŠุฉ ุชู„ุช
610
00:47:46,350 --> 00:47:51,730
ุดู‡ูˆุฑ ุจุนุฏ ุนู…ู„ูŠุฉ ุงู„ุฒุฑุงุนุฉ ุงู„ู€ acute graft versus host
611
00:47:51,730 --> 00:47:57,060
disease ุจูŠู†ุซู„ ุทุจุนู‹ุง accelerated inflammatory
612
00:47:57,060 --> 00:48:04,060
response ูŠุนู†ูŠ response ุนุงู„ูŠ against foreign
613
00:48:04,060 --> 00:48:08,960
antigen ุทุจุนู‹ุง ุงู„ู€ host ู‚ุงู„ ู„ู‡ antigen ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ
614
00:48:08,960 --> 00:48:12,520
donor lymphocyte encounter tissue the recipient
615
00:48:12,520 --> 00:48:20,500
that has been damaged to an underlying disease ูˆ
616
00:48:20,500 --> 00:48:28,420
ุงู„ู†ุงุณ ู‡ุฏูˆู„ ูƒู…ุง ู‚ู„ู†ุง ู„ูƒู… ูŠูƒูˆู†ูˆุง ู…ุชุนุฑุถูŠู† ู„ุฅู…ุง ุจุฑูŠ
617
00:48:28,420 --> 00:48:33,440
ู‡ูŠู…ูˆุจูŠุชูƒุณู„ ุชุฑุงู†ุณุจู„ุงู†ุชูŠุดู† ุซูŠุฑุงุจูŠ ุจุฑุงุฏูŠุงุดู† ุฃูˆ
618
00:48:33,440 --> 00:48:39,060
ุจูƒูŠู…ูˆุซูŠุฑุงุจูŠ. In human, graft-versus-host disease may
619
00:48:39,060 --> 00:48:43,460
produce splenomegaly ู†ูุณ ุฏูˆู„ุฉ or hepatomegaly or
620
00:48:43,460 --> 00:48:47,720
lymphadenopathy or diarrhea, anemia, weight loss
621
00:48:47,720 --> 00:48:50,280
and other disorders in which the underlying cause
622
00:48:50,280 --> 00:48:54,540
are inflammation ุฃูˆ ุงู„ู€ Destruction ู…ู† ู‡ุฐุง ุงู„ู…ูˆุถูˆุน
623
00:48:54,540 --> 00:48:58,520
. It is usually graft-versus-host disease is
624
00:48:58,520 --> 00:49:04,640
initiated by donor derived T cell ุชุนุฑูุช ุนู„ู‰
625
00:49:04,640 --> 00:49:09,900
Recipient MHC antigen and minor H antigen as
626
00:49:09,900 --> 00:49:15,840
foreign ูˆุงู„ู€ procedure ุงู„ุฃุณุงุณูŠ ุฃูˆ ุงู„ู…ุซุงู„ูŠ are used
627
00:49:15,840 --> 00:49:21,350
to eliminate ู†ูŠูˆู…ูˆู„ู…ุง ูŠุนู…ู„ูˆุง ุงู„ู€ hemopoietic cell
628
00:49:21,350 --> 00:49:24,030
transplantation ุจูŠุนู…ู„ูˆุง elimination ู„ู„ู€ T cell ู…ู†
629
00:49:24,030 --> 00:49:29,790
donor hemopoietic stem cell sources ู„ูƒู† ุจุชุจู‚ู‰ ุงู„ู€
630
00:49:29,790 --> 00:49:36,330
pluripotent stem cell ุฃูŠุถู‹ุง ู…ู…ูƒู† ุชุนุทูŠ ุฎู„ุงูŠุง ุฃูˆ
631
00:49:36,330 --> 00:49:40,550
ุชูˆู„ุฏู†ุง ุฎู„ุงูŠุง ู…ู† ุงู„ู€ T lymphocyte which are active
632
00:49:43,230 --> 00:49:45,290
ู…ุนุธู… ุงู„ู†ุงุณ ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ
633
00:49:45,290 --> 00:49:46,870
ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช
634
00:49:46,870 --> 00:49:47,730
ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ
635
00:49:47,730 --> 00:49:48,690
ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง
636
00:49:48,690 --> 00:49:49,730
ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ
637
00:49:49,730 --> 00:49:50,270
ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช
638
00:49:50,270 --> 00:49:51,850
ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ
639
00:49:51,850 --> 00:49:54,530
ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง
640
00:49:54,530 --> 00:49:57,140
ููŠ ุงู„ุงู„ุชู‡ุงุจุงุช ุงู„ู„ูŠ ุจูŠุดุชุบู„ูˆุง ุนู† ุทุฑูŠู‚ ุงู„ู€ Inflammatory
641
00:49:57,140 --> 00:49:59,680
Reaction ุจูŠุญุตู„ ููŠ ุงู„ู€ cytokine release ุฃุดู‡ุฑู‡ุง
642
00:49:59,680 --> 00:50:03,440
TNF alpha ูˆ IL-1 ุดูˆ ุจูŠุนู…ู„ูˆุงุŸ ู‚ุงู„ูˆุง
643
00:50:03,440 --> 00:50:06,440
ู‡ุฏูˆู„ ุจูŠุนู…ู„ูˆุง recruitment ู„ู„ู€ inflammatory cell
644
00:50:06,440 --> 00:50:10,120
inflammatory cell ูˆุจุงู„ุชุงู„ูŠ ุจุชูŠุฌูŠ ุจุชุณุงุนุฏ ุจุชุฒูŠุฏ
645
00:50:10,120 --> 00:50:15,260
ุงู„ุถุฑุฑ ูŠุนู†ูŠ ุจุชุณุงุนุฏ ููŠ ุฒูŠุงุฏุฉ ุงู„ู€ destruction of
646
00:50:15,260 --> 00:50:19,080
cell ุทุจุนู‹ุง
647
00:50:19,080 --> 00:50:22,540
unless the reaction is controlledุงู„ุดูŠุก ุงู„ู„ูŠ ุจูŠุญุฏุซ
648
00:50:22,540 --> 00:50:26,120
ููŠ ุงู„ู…ุฑูŠุถ ู‡ูˆ ุฃู† ุงู„ู…ุฑุถ ุจูŠุณุชุนู…ู„ ูˆุจูŠู‡ุงุฌู… ู…ูŠูƒุงู†ูŠุฒู…
649
00:50:26,120 --> 00:50:30,320
ุงู„ุฏูุงุน ุงู„ู…ู†ุงุนูŠ ูˆุจุงู„ุชุงู„ูŠ
650
00:50:30,320 --> 00:50:33,580
ู…ู…ูƒู† ุชุคุฏูŠ ุฅู„ู‰ ุงู„ูˆูุงุฉ ู„ุฃู†ู‡ ุจูŠุตูŠุฑ ููŠ ุงู„ู…ุฑูŠุถ ูˆูƒุฃู†ู‡
651
00:50:33,580 --> 00:50:39,240
ุจูŠูุนุงู†ูŠ ู…ู† status of immunodeficiency ูˆุจุงู„ุชุงู„ูŠ ู…ู…ูƒู†
652
00:50:39,240 --> 00:50:44,400
ุชุคุฏูŠ ุฅู„ู‰ ุงู„ูˆูุงุฉ ู„ูƒู† ูŠู…ูƒู† ุฃู† ูŠูƒูˆู† ู…ูุนุงู„ุฌ ุจู…ุฌู…ูˆุนุฉ ู…ู†
653
00:50:44,400 --> 00:50:48,020
ุงู„ุฃุฏูˆูŠุฉ ุงู„ู…ุนุฑูˆูุฉ ุจุงู„ู…ู†ุงุนุฉ ู…ุซู„ Cyclosporin
654
00:50:48,020 --> 00:50:49,020
ูˆTacrolimus
655
00:50:53,930 --> 00:51:00,030
ุจุณุฑุนุฉ ู…ู† Methotrexate ูƒูƒูŠู…ูˆุซูŠุฑุงุจูŠ ู‡ุฐุง ุจุงู„ู†ุณุจุฉ
656
00:51:00,030 --> 00:51:05,190
ู„ู„ู‡ูŠู…ูˆุจูŠุชูƒ stem cell transplantation ุงู„ู…ูˆุถูˆุน ุงู„ุซุงู†ูŠ
657
00:51:05,190 --> 00:51:07,870
ุงู„ู„ูŠ ุจุฏู†ุง ู†ุญูƒูŠ ููŠู‡ ููŠ ุงู„ู…ูˆุถูˆุนูŠู† ุงู„ุชุงู„ูŠูŠู† ุงู„ู„ูŠ ู‡ูˆ
658
00:51:07,870 --> 00:51:11,670
ู…ูˆุถูˆุน ุงู„ููŠุชุณ ู‡ูˆ ุจู„ุนู† tolerated allograft
659
00:51:15,600 --> 00:51:21,480
ูˆุฌุงู„ู‡ ููŠ ุนุฏุฉ ุฃุณุจุงุจ ุจุงู„ู†ุณุจุฉ ู„ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ุฃูˆู„ ุณุจุจ ุฃู†
660
00:51:21,480 --> 00:51:25,880
ุงู„ู€ fetus express paternal amnesty antigen that is
661
00:51:25,880 --> 00:51:30,660
not expressed by mother ูˆุจุงู„ุชุงู„ูŠ ุงู„ู…ูุฑูˆุถ ุฃู†ู‡ to be
662
00:51:30,660 --> 00:51:33,920
rejected by the mother as an allograft ู„ูƒู† ุงู„ู„ูŠ
663
00:51:33,920 --> 00:51:41,240
ุจูŠุตูŠุฑ ุฃู†ู‡ ู…ุง ุจูŠุตูŠุฑ ุงู„ู…ูุฑูˆุถ
664
00:51:41,240 --> 00:51:44,830
ุฃู† ุงู„ู€ motherูƒุงู† ู…ุนุฑูˆู ุฃู† ุงู„ุฃุฌุณุงู… ุงู„ู…ุถุงุฏุฉ ุจุชุชูุงุนู„ ู…ุน
665
00:51:44,830 --> 00:51:49,010
ุฃู†ุชูŠุฌูŠู†ุงุช ุงู„ููŠุทุณ ู…ุซู„ ู…ุง ุจูŠุญุฏุซ ููŠ ุญุงู„ุฉ ุงู„ู€ Rh antibodies
666
00:51:49,010 --> 00:51:59,790
ุจุงู„ุฅุถุงูุฉ ู„ุฃู† ุงู„ุฃู… ูƒุงู†ุช ุจุชุฎู„ู ูƒุซูŠุฑู‹ุง multiparous woman
667
00:51:59,790 --> 00:52:09,530
ุนู†ุฏู‡ุง ุฃุฌุณุงู… ู…ุถุงุฏุฉ ุถุฏ MSC antigens ุจุดูƒู„ ูƒุจูŠุฑ ุฅู„ุง ุฃู†
668
00:52:09,530 --> 00:52:19,230
ู„ูŠุณุช ุฃุฌุณุงู… ู…ุถุงุฏุฉare harmless to the fetus ู‡ุฐู‡ ู†ู‚ุทุฉ
669
00:52:19,230 --> 00:52:26,710
ู…ู‡ู…ุฉ they cannot cross the placenta ู„ุฃุณุจุงุจ ุซุงู†ูŠุฉ
670
00:52:26,710 --> 00:52:31,690
mother does not produce cytotoxic T cell against
671
00:52:31,690 --> 00:52:39,830
the fetus ุดูŠุก ุซุงู„ุซ trophoblast ุจุชุงุนุฉ ุงู„ููŠุชุณ ุงู„ู„ูŠ
672
00:52:39,830 --> 00:52:44,250
ุจุชูƒูˆู† ุงู„ู€ outer layer of placenta ูˆุงู„ู„ูŠ ู‡ูŠ on
673
00:52:44,250 --> 00:52:47,950
direct contact with material tissue Do not express
674
00:52:47,950 --> 00:52:53,070
polymorphic MHC class 1 ุฃูˆ class 2 molecule ูˆู„ูƒู†
675
00:52:53,070 --> 00:52:56,830
they express another polymorphic class of MHC
676
00:52:56,830 --> 00:53:01,410
antigen ุจูŠุณู…ูˆู‡ class 1B MHC molecule ุฃูˆ ุจูŠุณู…ูˆู‡
677
00:53:01,410 --> 00:53:06,850
HLA-G ูˆุจุงู„ุชุงู„ูŠ ุงู„ู€ fetal trophoblast does not prime
678
00:53:06,850 --> 00:53:11,230
for cellular immune responseุงู„ุชูŠ ู…ุฑุชุจุทุฉ ุจุงู„ู€
679
00:53:11,230 --> 00:53:16,650
Allograft Rejection ุจู„ ุจุงู„ุนูƒุณ ุงู„ู€ HLA-G ุจุชู…ู†ุญ ุงู„ู€
680
00:53:16,650 --> 00:53:23,050
ligand ู„ู„ู€ KIR ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ู€ maternal NK cell
681
00:53:23,050 --> 00:53:29,450
ูˆุจุงู„ุชุงู„ูŠ ุจูŠู…ู†ุน ู†ุดุงุทู‡ุง ุจูŠู…ู†ุน ุนู…ู„ูŠุฉ ู‚ุชู„ ุงู„ู€ fetal
682
00:53:29,450 --> 00:53:33,870
cell by NK cell ุดูˆ ุจูŠุนู…ู„ุŸ ู…ุฑุชุจุท ุจุงู„ู€ K inhibitory
683
00:53:33,870 --> 00:53:37,440
receptor Killer Inhibitory Receptor ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุนู„ู‰
684
00:53:37,440 --> 00:53:47,680
ุณุทุญ ุงู„ู€ NK cell ุจุชุงุนุฉ ุงู„ู€ fetus HLA-G ุฃูŠุถู‹ุง Expressed in
685
00:53:47,680 --> 00:53:52,720
Thymic Medullary Epithelium ูˆู‡ุฐุง ุจูŠุคูƒุฏ ุฃู† T cell
686
00:53:52,720 --> 00:54:00,860
tolerance to this molecule ุดุงูุชู‡ ู‚ุจู„ ู‡ูŠูƒ ุฃูŠุถู‹ุง No
687
00:54:00,860 --> 00:54:06,600
cell expressing large amountุฃูˆ MSC Class 2 ู…ุซู„ู‹ุง
688
00:54:06,600 --> 00:54:13,660
ุฏู„ุชุฑุงุชูƒุณู„ ุงู„ุชูŠ ุชู… ูˆุฌูˆุฏู‡ุง ููŠ ุงู„ู…ุดูŠู…ุฉ ู…ุง ููŠุด Alpha
689
00:54:13,660 --> 00:54:17,980
-Fetoprotein ู‡ูˆ ุจุฑุถู‡ ุจุฑูˆุชูŠู† ุจูŠุตู†ุน ููŠ ุงู„ู€ yolk sac
690
00:54:17,980 --> 00:54:23,680
ูˆููŠ ุงู„ู€ fetal liver ูˆุจูŠุนุชุจุฑ important in the survival of
691
00:54:23,680 --> 00:54:29,240
the fetus ุจูŠุณุชุฎุฏู… ู„ุฅู†ู‡ ุจูŠุนุชุจุฑ ูƒู€ immunosuppressive
692
00:54:29,240 --> 00:54:33,040
drug ู„ู‡ immunosuppressive properties
693
00:54:35,540 --> 00:54:39,980
ูˆุจุงู„ุชุงู„ูŠ ุงู„ููŠุชุณ ู„ุง ูŠุดุชุบู„ ููŠ ุฌู‡ุงุฒ ู…ู†ุงุนูŠ ุจุงู„ุนูƒุณ
694
00:54:39,980 --> 00:54:46,640
ุจูŠุนุชุจุฑ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠ ุฌู‡ุงุฒ
695
00:54:46,640 --> 00:54:48,160
ู…ู†ุงุนูŠ ูˆ ุจูŠุนุชุจุฑ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ
696
00:54:48,160 --> 00:54:48,500
ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ
697
00:54:48,500 --> 00:54:48,900
ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ
698
00:54:48,900 --> 00:54:49,060
ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ
699
00:54:49,060 --> 00:54:49,080
ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ
700
00:54:49,080 --> 00:54:53,360
ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ ููŠู‡ ู…ูˆุฌูˆุฏ
701
00:54:53,360 --> 00:55:03,980
ููŠู‡ ู…ูˆุฌูˆุฏ
702
00:55:03,980 --> 00:55:09,580
ููŠ ูˆููŠ ุญุงู„ุงุช ุงู„ู€ diabetic ulcer ูˆุงู„ู€ venous ulcer
703
00:55:09,580 --> 00:55:18,260
ูˆุบุงู„ุจู‹ุง ุจุชุดูŠุฑ commonly to autologous ุทุจุนู‹ุง recently
704
00:55:18,260 --> 00:55:22,700
artificial skin has been used ูŠุนู†ูŠ ุจุฏุคูˆุง ูŠุตู†ุนูˆุง
705
00:55:22,700 --> 00:55:25,800
consisting of stromal element and cultured cell
706
00:55:25,800 --> 00:55:30,360
for allogenic or xenogenic origin ุตุงุฑูˆุง ูŠุณุชุฎุฏู…ูˆุง
707
00:55:30,360 --> 00:55:31,140
ุงู„ู„ูŠ ู‡ูˆ
708
00:55:35,440 --> 00:55:43,300
ูˆุฃุญุฏ ู…ู† ุฃุตูˆู„ ุงู„ู„ูŠ ู‡ูˆ ู…ุตู†ุนุฉ kidney
709
00:55:43,300 --> 00:55:48,500
ุฒูŠ ู…ุง ููŠ ุญุงู„ุงุช ุงู„ู€ renal failure ุทุจุนู‹ุง ุงู„ู€ graft
710
00:55:48,500 --> 00:55:58,540
survival ุจูŠุฒูŠุฏ ุนู† 85% ู„ู…ุฏุฉ ุณู†ุฉ ุญุชู‰ ูˆุฅู† ูƒุงู† unrelated
711
00:55:58,540 --> 00:56:05,920
matching is present ุทุจุนู‹ุง ู…ุด ุณู†ุฉ ุฃู†ุง ุจู‚ูˆู„ ุงู„ูŠูˆู… ููŠ
712
00:56:05,920 --> 00:56:10,680
ุงู„ู€ kidney ุงู„ูŠูˆู… ูˆุตู„ by using immunosuppressive
713
00:56:10,680 --> 00:56:16,500
regimen ู„ุบุงูŠุฉ ุขุฎุฑ ุฃุญุฏ ุงู„ุฃุจุญุงุซ ุจุชู‚ูˆู„ ู„ุบุงูŠุฉ ุนุดุฑูŠู†
714
00:56:16,500 --> 00:56:20,740
ูˆุฎู…ุณ ูˆุนุดุฑูŠู† ุณู†ุฉ liver ููŠ ุญุงู„ุฉ ุงู„ู€ hepatocellular ุฃูˆ ุงู„ู€
715
00:56:20,740 --> 00:56:25,320
biliary atresia successful in about two third of
716
00:56:25,320 --> 00:56:30,320
recipient for one year heart ููŠ ุญุงู„ุฉ ุงู„ู€ cardiac
717
00:56:30,320 --> 00:56:36,750
failure survival rate ุจุชูˆุตู„ ุฅู„ู‰ 80% ู„ู…ุฏุฉ ุณู†ุฉ ุงู„ู€
718
00:56:36,750 --> 00:56:39,530
lung ููŠ ุญุงู„ุงุช ุงู„ู€ advanced pulmonary ุฃูˆ
719
00:56:39,530 --> 00:56:45,050
cardiopulmonary diseases ูˆุบุงู„ุจู‹ุง ุจุณุฑุนุฉ
720
00:56:45,050 --> 00:56:47,050
transplantation together with heart
721
00:56:47,050 --> 00:56:51,390
transplantation ุฏูˆู„ ู…ุฑูˆุง ููŠ ุญุงู„ุงุช ุงู„ู€ incurable
722
00:56:51,390 --> 00:56:56,190
ู„ูˆูƒูŠู…ูŠุง ู„ู†ููˆู…ุง congenital immunodeficiency ูˆ risk
723
00:56:56,190 --> 00:57:01,180
of graft versus host disease transplantation of a
724
00:57:01,180 --> 00:57:04,180
hemopoietic cell has been used ุนุดุงู† ูŠุฎูู ู…ู†
725
00:57:04,180 --> 00:57:07,860
ุงู„ุดุฑุณุฉ graft versus his disease ุจุฏุคูˆุง ูŠุณุชุฎุฏู…ูˆุง
726
00:57:07,860 --> 00:57:12,940
hemopoietic stem cell ู…ุด ุจูˆู„ูŠู…ุงุฑ ูƒูˆุฑู†ูŠุง ููŠ ุญุงู„ุฉ ุงู„ู€
727
00:57:12,940 --> 00:57:18,060
blindness actually matching is not advantageous ู…ุด
728
00:57:18,060 --> 00:57:24,900
ูƒุซูŠุฑ ู…ูŠุฒุฉ ู„ุฃู† ุงู„ูƒูˆุฑู†ูŠุง ุฃูˆ ุงู„ู€ eye is privileged
729
00:57:24,900 --> 00:57:29,370
site immunoprivileged site ูˆุจุงู„ุชุงู„ูŠ ู…ุง ููŠ
730
00:57:29,370 --> 00:57:34,610
lymphatic drainage pancreas ููŠ ุญุงู„ุงุช ุงู„ู€ diabetes
731
00:57:34,610 --> 00:57:38,770
mellitus pancreas and kidney transplantation
732
00:57:38,770 --> 00:57:47,710
ุงู„ุฅุซู†ูŠู† ู…ุน ุจุนุถ success rate ูŠุนู†ูŠ ุชู‚ุฑูŠุจู‹ุง ุจุชู†ุฌุญ ู…ู†
733
00:57:47,710 --> 00:57:53,490
ุงู„ู€ kidney transplant ูˆุจู‡ูŠูƒ ุจู†ูƒูˆู† ุงู†ุชู‡ูŠู†ุง ู…ู† ู…ุญุงุถุฑุฉ ุงู„ู€
734
00:57:53,490 --> 00:57:57,710
kidney transplant ุงู„ู€ transplantation ูŠุนู†ูŠ ุฃุฑุฌูˆ ุฃู†
735
00:57:57,710 --> 00:58:03,630
ุชูƒูˆู† ุฃูุฏุชูƒู… ูˆุงุณุชู…ุชุนุชู… ุจู‡ุฐู‡ ุงู„ู…ุญุงุถุฑุฉ ูˆ ุดูƒุฑุงู‹